https://curecurrent.com/trials/palliative-hypofractionated-radiotherapy-in-advanced-incurable-breast-cancer-34001https://curecurrent.com/trials/a-real-world-analysis-of-concomitant-medication-use-among-metastatic-breast-cancer-patients-treated-with-cdk4-6-inhibito-34002https://curecurrent.com/trials/pre-pectoral-alloderm-to-reinforce-tissues-in-tissue-expander-breast-reconstruction-34003https://curecurrent.com/trials/quantitative-assessment-of-diffusion-spectrum-imaging-in-breast-cancer-34004https://curecurrent.com/trials/real-time-interactive-digital-healthcare-system-in-patients-with-breast-cancer-randomized-controlled-trial-34005https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-pertuzumab-trastuzumab-docetaxel-versus-placebo-trastuzumab-docetaxel-in-34006https://curecurrent.com/trials/inhibiting-fatty-acid-synthase-to-improve-efficacy-of-neoadjuvant-chemotherapy-34007https://curecurrent.com/trials/fbntp-imaging-of-breast-cancer-34008https://curecurrent.com/trials/drug-drug-interaction-study-of-entinostat-and-exemestane-in-postmenopausal-women-with-er-breast-cancer-34009https://curecurrent.com/trials/neratinib-dose-escalation-regimen-for-her2-positive-early-breast-cancer-34010https://curecurrent.com/trials/study-of-single-agent-pembrolizumab-mk-3475-versus-single-agent-chemotherapy-for-metastatic-triple-negative-breast-cance-34011https://curecurrent.com/trials/genotype-and-phenotype-in-early-onset-breast-cancer-in-young-women-on-the-two-shores-of-the-mediterranean-sea-34012https://curecurrent.com/trials/map-treatment-plan-with-afinitor-for-postmenopausal-women-with-advanced-hr-breast-cancer-34013https://curecurrent.com/trials/transitioning-care-perspectives-of-older-women-with-early-breast-cancer-on-current-telemedicine-modalities-34014https://curecurrent.com/trials/circulating-microrna-21-expression-level-before-and-after-neoadjuvant-systemic-therapy-in-breast-carcinoma-34015https://curecurrent.com/trials/breast-cancer-and-intrauterine-contraception-34016https://curecurrent.com/trials/assessment-of-breast-cancer-related-arm-lymphedema-34017https://curecurrent.com/trials/a-study-of-pertuzumab-with-high-dose-trastuzumab-for-the-treatment-of-human-epidermal-growth-factor-receptor-2-her2-posi-34018https://curecurrent.com/trials/randomized-trial-of-neo-adjuvant-chemotherapy-with-or-without-metformin-for-her2-positive-operable-breast-cancer-34019https://curecurrent.com/trials/evaluation-of-the-effect-of-metformin-on-metastatic-breast-cancer-as-adjuvant-treatment-34020https://curecurrent.com/trials/phase-iii-study-of-docetaxel-ramucirumab-or-placebo-in-breast-cancer-34021https://curecurrent.com/trials/study-of-clr457-administered-orally-in-adult-patients-with-advanced-solid-malignancies-34022https://curecurrent.com/trials/axillary-sentinel-or-targeted-lymph-node-biopsy-alone-after-neoadjuvant-chemotherapy-in-node-positive-breast-cancer-34023https://curecurrent.com/trials/accuracy-of-contrast-enhanced-mamography-in-predicting-response-of-breast-cancer-post-neoadjuvant-chemotherapy-34024https://curecurrent.com/trials/effectiveness-and-safety-of-fulvestrant-in-postmenopausal-women-with-advanced-breast-cancer-hr-her2-34025https://curecurrent.com/trials/the-effect-of-oral-cryotherapy-on-anticipatory-acute-and-late-nausea-and-vomiting-in-breast-cancer-patients-34026https://curecurrent.com/trials/multidisciplinary-shared-decision-making-of-fertility-preservation-in-young-women-with-breast-cancer-34027https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-34028https://curecurrent.com/trials/stay-on-track-a-study-of-exercise-effects-during-radiation-34029https://curecurrent.com/trials/impact-of-a-psychoeducational-intervention-on-expectations-and-coping-in-young-women-exposed-to-a-high-hboc-risk-34030https://curecurrent.com/trials/sentinel-lymph-node-biopsy-in-clinically-node-negative-early-breast-cancer-patients-after-neoadjuvant-chemotherapy-34031https://curecurrent.com/trials/clinical-study-of-adjuvant-therapy-on-post-menopausal-women-with-breast-cancer-under-the-guidance-of-the-results-of-preo-34032https://curecurrent.com/trials/comparative-study-of-scalp-cooling-system-and-chemical-cold-cap-cohair-study-34033https://curecurrent.com/trials/to-accurately-assess-lymph-node-response-to-nact-by-wire-localization-of-clip-marked-lymph-nodes-34034https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-versus-chemotherapy-in-premenopausal-patients-with-er-her2-breast-cancer-34035https://curecurrent.com/trials/alternative-non-cross-resistant-adjuvant-chemotherapy-for-operable-breast-cancer-non-response-to-primary-chemotherapy-34036https://curecurrent.com/trials/the-association-of-hormonal-intake-and-demographic-factors-with-breast-cancer-risk-an-egyptian-case-controlled-study-34037https://curecurrent.com/trials/rc48-for-neoadjuvant-chemotherapy-of-her2-positive-breast-cancer-34038https://curecurrent.com/trials/efficacy-of-aquatic-physiotherapy-in-the-treatment-of-upper-limb-lymphedema-in-women-with-breast-cancer-34039https://curecurrent.com/trials/nanoparticle-albumin-bound-nab-paclitaxel-cyclophosphamide-in-early-stage-breast-cancer-34040https://curecurrent.com/trials/neoadjuvant-treatment-of-breast-cancer-34041https://curecurrent.com/trials/cisplatin-azd-1775-in-breast-cancer-34042https://curecurrent.com/trials/a-study-of-pegylated-liposomal-doxorubicin-and-cyclophosphamide-in-her2-negative-stage-i-and-ii-breast-cancer-patients-34043https://curecurrent.com/trials/the-effect-of-intermittent-fasting-on-body-composition-in-women-with-breast-cancer-34044https://curecurrent.com/trials/neo-adjuvant-gemcitabine-epirubicin-abi-007-gea-in-locally-advanced-or-inflammatory-breast-cancer-34045https://curecurrent.com/trials/cipterbin-combined-with-vinorelbine-in-the-treatment-of-her2-positive-mbc-34046https://curecurrent.com/trials/ixabepilone-and-cyclophosphamide-as-neoadjuvant-therapy-in-her-2-negative-breast-cancer-34047https://curecurrent.com/trials/fate-nk100-as-monotherapy-and-in-combination-with-monoclonal-antibody-in-subjects-with-advanced-solid-tumors-34048https://curecurrent.com/trials/cox-inhibition-and-biomarkers-during-neoadjuvant-chemoendocrine-therapy-for-er-her2-stage-i-iii-breast-cancer-34049https://curecurrent.com/trials/light-scattering-spectroscopy-for-detection-of-breast-cancer-34050https://curecurrent.com/trials/study-to-assess-food-effect-on-pharmacokinetics-of-entinostat-in-subjects-with-breast-cancer-or-non-small-cell-lung-canc-34051https://curecurrent.com/trials/automated-method-for-breast-cancer-detection-34052https://curecurrent.com/trials/analysis-of-breast-conserving-surgery-plus-whole-breast-irradiation-versus-mastectomy-34053https://curecurrent.com/trials/toll-like-receptor-tlr-7-agonist-cyclophosphamide-and-radiotherapy-for-breast-cancer-with-skin-metastases-34054https://curecurrent.com/trials/imaging-of-in-vivo-sigma-2-receptor-expression-with-18f-iso-1-positron-emission-tomography-in-metastatic-breast-cancer-34055https://curecurrent.com/trials/empowering-latinas-to-obtain-breast-cancer-screenings-34056https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-with-digital-breast-tomosynthesis-for-patients-with-newly-diagnosed-breast-cancer-34057https://curecurrent.com/trials/genetic-predictors-to-acupuncture-response-for-arthralgia-induced-by-aromatase-inhibitors-in-patients-with-breast-cancer-34058https://curecurrent.com/trials/bevacizumab-given-with-either-anastrozole-or-fulvestrant-with-trastuzumab-for-postmenopausal-metastatic-breast-cancer-34059https://curecurrent.com/trials/effects-of-music-or-hypnotherapy-on-cancer-patients-during-chemotherapy-34060https://curecurrent.com/trials/the-effects-of-perioperative-pecs-block-during-robotic-breast-surgery-and-breast-reconstruction-34061https://curecurrent.com/trials/kn026-in-patients-with-her2-expressing-breast-cancer-and-gastric-cancer-34062https://curecurrent.com/trials/invincible-trial-intratumoral-int230-6-in-breast-cancer-34063https://curecurrent.com/trials/assessing-breast-density-s-value-in-imaging-a-comparative-effectiveness-study-34064https://curecurrent.com/trials/naltrexone-rct-for-treatment-emergent-fatigue-in-patients-receiving-radiation-therapy-for-breast-cancer-34065https://curecurrent.com/trials/pet-ct-guided-fulvestrant-therapy-for-patients-with-recurrent-or-metastatic-breast-cancer-34066https://curecurrent.com/trials/a-safety-and-tolerability-study-of-incagn02390-in-select-advanced-malignancies-34067https://curecurrent.com/trials/evaluation-of-mailers-promoting-mammogram-screening-34068https://curecurrent.com/trials/pilot-study-of-a-pharmacy-intervention-for-older-adults-with-cancer-34069https://curecurrent.com/trials/sexual-health-and-rehabilitation-after-ovarian-suppression-treatment-34070https://curecurrent.com/trials/outcomes-of-breast-conservative-surgery-for-post-chemotherapy-tumour-size-after-response-to-neoadjuvant-chemotherapy-34071https://curecurrent.com/trials/acupuncture-for-stiffness-of-joint-related-to-aromatase-inhibitors-in-patients-with-early-stage-breast-cancer-34072https://curecurrent.com/trials/generation-of-cancer-antigen-specific-t-cells-from-human-induced-pluripotent-stem-cells-ipsc-for-research-and-potential-34073https://curecurrent.com/trials/precision-acupuncture-in-the-treatment-of-peripheral-neuropathy-after-taxanes-chemotherapy-in-breast-cancer-34074https://curecurrent.com/trials/analysis-of-patient-understanding-of-radiation-therapy-among-patients-with-breast-cancer-34075https://curecurrent.com/trials/esp-in-breast-surgery-due-to-cancer-34076https://curecurrent.com/trials/combination-of-nivolumab-and-ipilimumab-in-breast-ovarian-and-gastric-cancer-patients-34077https://curecurrent.com/trials/bemcentinib-bgb324-in-combination-with-pembrolizumab-in-patients-with-tnbc-34078https://curecurrent.com/trials/talazoparib-for-neoadjuvant-treatment-of-germline-brca1-2-mutation-patients-with-early-human-epidermal-growth-factor-rec-34079https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-venetoclax-in-combination-with-trastuzumab-emtansine-in-patients-with-prev-34080https://curecurrent.com/trials/adjuvant-whole-breast-irradiation-in-five-fractions-versus-fifteen-fractions-in-early-breast-cancer-34081https://curecurrent.com/trials/partial-pten-deletion-in-breast-cancer-34082https://curecurrent.com/trials/evaluation-of-the-effects-of-the-couple-based-family-nursing-for-women-with-breast-cancer-34083https://curecurrent.com/trials/factors-affecting-functionality-in-breast-cancer-survivors-34084https://curecurrent.com/trials/evaluation-of-the-prevalence-of-pelvic-static-disorders-in-women-with-localized-breast-cancer-34085https://curecurrent.com/trials/music-as-a-perioperative-therapy-in-breast-cancer-patients-34086https://curecurrent.com/trials/effect-of-gm1-in-prevention-of-taxanes-induced-neurotoxicity-in-operable-breast-cancer-34087https://curecurrent.com/trials/lifestyle-program-scalable-nutrition-and-physical-activity-for-the-improvement-of-nutrition-and-physical-activity-in-sta-34088https://curecurrent.com/trials/biomarker-study-of-the-antitumoral-activity-of-denosumab-in-the-pre-operative-setting-of-early-breast-cancer-34089https://curecurrent.com/trials/super-selective-intra-arterial-cerebral-infusion-of-trastuzumab-for-the-treatment-of-cerebral-metastases-of-her2-neu-pos-34090https://curecurrent.com/trials/living-well-after-breast-surgery-34091https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-antitumor-activity-of-x4p-001-in-combination-with-tnbc-34092https://curecurrent.com/trials/does-intra-operative-marginprobe-use-reduce-re-excision-rates-34093https://curecurrent.com/trials/optimizing-irradiation-through-molecular-assesment-of-lymph-node-after-primary-systemic-treatment-34094https://curecurrent.com/trials/effect-of-vandetanib-on-cellular-markers-in-invasive-breast-cancer-34095https://curecurrent.com/trials/oncology-targeted-nlp-powered-federated-hyper-architecture-and-data-sharing-framework-for-health-data-reusability-34096https://curecurrent.com/trials/pilot-study-of-effects-of-duavee-on-imaging-and-blood-biomarkers-in-women-with-menopausal-symptoms-34097https://curecurrent.com/trials/web-based-oncofertility-support-tool-for-reproductive-age-women-with-breast-cancer-34098https://curecurrent.com/trials/a-registry-study-of-permanent-breast-seed-implant-34099https://curecurrent.com/trials/the-technical-operations-and-standard-clinical-application-protocol-of-cbbct-in-diagnostic-process-of-breast-cancer-34100https://curecurrent.com/trials/safety-and-efficacy-of-libigel-for-treatment-of-hypoactive-sexual-desire-disorder-in-postmenopausal-women-34101https://curecurrent.com/trials/effect-of-oxygen-inhalation-on-fatigue-after-chemotherapy-of-breast-cancer-in-high-altitude-area-34102https://curecurrent.com/trials/trastuzumab-and-oxaliplatin-in-patients-with-metastatic-breast-cancer-34103https://curecurrent.com/trials/camrelizumab-in-combination-with-pld-and-losartan-in-patients-with-tnbc-who-have-received-1-line-of-chemotherapy-34104https://curecurrent.com/trials/comprehensive-gene-sequencing-in-guiding-treatment-recommendations-patients-with-metastatic-or-recurrent-solid-tumors-34105https://curecurrent.com/trials/aromasin-interventional-study-of-early-invasive-breast-cancer-patients-in-china-34106https://curecurrent.com/trials/weekly-gemcitabine-epirubicin-and-docetaxel-in-locally-advanced-or-inflammatory-breast-cancer-34107https://curecurrent.com/trials/abcb1-snps-as-predictors-of-pipn-34108https://curecurrent.com/trials/a-home-based-walking-program-and-rtms-in-helping-breast-cancer-survivors-get-more-physical-activity-34109https://curecurrent.com/trials/safety-and-efficacy-of-iv-nerofe-followed-by-doxorubicin-in-metastatic-ovarian-cancer-and-triple-negative-breast-cancer-34110https://curecurrent.com/trials/comparison-of-microwave-ablation-with-breast-conserving-surgery-for-breast-tumor-34111https://curecurrent.com/trials/study-of-estrogen-levels-in-premenopausal-women-who-have-undergone-surgery-for-breast-cancer-and-are-receiving-triptorel-34112https://curecurrent.com/trials/phase-ii-randomized-trial-evaluating-neoadjuvant-therapy-with-neratinib-and-or-trastuzumab-followed-by-postoperative-tra-34113https://curecurrent.com/trials/lapatinib-and-bevacizumab-for-metastatic-breast-cancer-34114https://curecurrent.com/trials/study-evaluating-efficacy-and-tolerability-of-veliparib-in-combination-with-temozolomide-tmz-or-in-combination-with-carb-34115https://curecurrent.com/trials/therapy-with-bevacizumab-bev-epirubicin-and-cyclophosphamide-followed-by-docetaxel-plus-trastuzumab-and-bev-given-as-neo-34116https://curecurrent.com/trials/fes-pet-for-patients-treated-on-nci-protocol-8762-34117https://curecurrent.com/trials/medial-vs-entire-supraclavicular-lymph-node-radiation-therapy-for-patients-with-invasive-breast-cancer-34118https://curecurrent.com/trials/predictive-blood-tests-for-severe-radiation-reactions-in-breast-cancer-patients-34119https://curecurrent.com/trials/efficacy-of-magnetic-resonance-guided-high-intensity-focused-ultrasound-for-the-ablation-of-breast-cancer-34120https://curecurrent.com/trials/car-t-hepatic-artery-infusions-or-pancreatic-venous-infusions-for-cea-expressing-liver-metastases-or-pancreas-cancer-34121https://curecurrent.com/trials/omitting-vs-doing-intraoperative-frozen-section-biopsy-for-margin-status-in-breast-conserving-surgery-34122https://curecurrent.com/trials/deep-inferior-epigastric-artery-flap-for-breast-reconstruction-34123https://curecurrent.com/trials/enhancing-physical-activity-adherence-after-breast-cancer-diagnosis-beat-cancer-ii-34124https://curecurrent.com/trials/neoadjuvant-camrelizumab-plus-chemotherapy-in-triple-negative-breast-cancer-34125https://curecurrent.com/trials/alterations-in-the-vaginal-microenvironment-using-a-non-pharmacological-intervention-34126https://curecurrent.com/trials/study-of-donepezil-in-female-breast-cancer-survivors-with-cognitive-dysfunction-34127https://curecurrent.com/trials/advanced-mr-techniques-for-breast-cancer-detection-34128https://curecurrent.com/trials/yoga-or-educational-wellness-class-for-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-undergoing-chemotherapy-34129https://curecurrent.com/trials/modradoc006-r-in-patients-with-breast-cancer-34130https://curecurrent.com/trials/carboplatin-cyclophosphamide-combined-with-atezolizumab-34131https://curecurrent.com/trials/alpelisib-fulvestrant-and-dapagliflozin-for-the-treatment-of-hr-her2-pik3ca-mutant-metastatic-breast-cancer-34132https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-fastscan-hifu-34133https://curecurrent.com/trials/myofascial-induction-in-breast-cancer-survivors-34134https://curecurrent.com/trials/stereotactic-radiosurgery-with-abemaciclib-ribociclib-or-palbociclib-in-treating-patients-with-hormone-receptor-positive-34135https://curecurrent.com/trials/multimodal-targeted-axillary-surgery-34136https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-sg001-in-combination-with-nab-paclitaxel-in-patients-with-advanced-triple-34137https://curecurrent.com/trials/pilot-study-of-the-effect-of-weight-loss-on-breast-tissue-and-blood-biomarkers-in-women-at-increased-risk-for-breast-can-34138https://curecurrent.com/trials/initial-assessment-of-18fdg-pet-mriin-determining-the-extent-of-systemic-disease-in-breast-cancer-patients-34139https://curecurrent.com/trials/characteristics-and-treatment-trends-of-young-breast-cancer-in-china-34140https://curecurrent.com/trials/tpvb-pecsb-espb-for-postmastectmy-pain-34141https://curecurrent.com/trials/feasibility-of-a-new-technology-for-isolating-circulating-tumour-cells-34142https://curecurrent.com/trials/pyrotinib-in-combination-with-letrozole-in-patients-with-her2-positive-er-positive-metastatic-breast-cancer-34143https://curecurrent.com/trials/neoadjuvant-with-trastuzumab-pyrotinib-plus-palbociclib-and-fulvestrant-in-her2-positive-er-positive-breast-cancer-34144https://curecurrent.com/trials/evaluation-of-biomarkers-associated-with-response-to-subsequent-therapies-in-subjects-with-her2-positive-metastatic-brea-34145https://curecurrent.com/trials/the-efficacy-and-safety-of-anlotinib-combined-with-fulvestrant-in-patients-with-advanced-breast-cancer-34146https://curecurrent.com/trials/alpha-lipoic-acid-in-breast-cancer-patients-34147https://curecurrent.com/trials/adjuvant-ribociclib-with-endocrine-therapy-in-hormone-receptor-her2-high-risk-early-breast-cancer-34148https://curecurrent.com/trials/study-for-women-and-men-with-hormone-receptor-positive-locally-advanced-or-metastatic-breast-cancer-34149https://curecurrent.com/trials/diagnostic-procedures-in-detecting-tumor-cells-in-the-bone-marrow-of-patients-undergoing-surgery-for-stage-i-stage-ii-or-34150https://curecurrent.com/trials/safety-study-of-chemotherapy-combined-with-dendritic-cell-vaccine-to-treat-breast-cancer-34151https://curecurrent.com/trials/pilot-study-to-investigate-targetable-metabolic-pathways-sustaining-triple-negative-breast-cancer-34152https://curecurrent.com/trials/safety-and-blood-immune-cell-study-of-anakinra-plus-physician-s-chemotherapy-choice-in-metastatic-breast-cancer-patients-34153https://curecurrent.com/trials/rwd-study-in-her2-mbc-patients-in-third-line-therapy-34154https://curecurrent.com/trials/the-mammography-and-ultrasonography-study-for-breast-cancer-screening-effectiveness-34155https://curecurrent.com/trials/sema4c-as-a-relapse-biomarker-in-breast-cancer-34156https://curecurrent.com/trials/improving-diagnosis-of-breast-cancer-by-using-a-combined-mri-and-positron-emission-mammography-mri-pem-system-34157https://curecurrent.com/trials/trial-of-ra-223-dichloride-in-combination-with-hormonal-therapy-and-denosumab-in-the-treatment-of-patients-with-hormone-34158https://curecurrent.com/trials/anastrozole-in-preventing-breast-cancer-in-postmenopausal-women-at-increased-risk-of-breast-cancer-34159https://curecurrent.com/trials/comparison-of-neoadjuvant-chemotherapy-with-weekly-paclitaxel-or-eribulin-followed-by-a-c-in-women-with-locally-advanced-34160https://curecurrent.com/trials/proton-accelerated-partial-breast-irradiation-34161https://curecurrent.com/trials/extended-follow-up-of-the-targit-a-trial-34162https://curecurrent.com/trials/adapted-physical-activity-apa-in-a-breast-cancer-population-34163https://curecurrent.com/trials/factors-influencing-decision-making-about-the-use-of-chemoprevention-in-women-at-increased-risk-for-breast-cancer-34164https://curecurrent.com/trials/imp321-eftilagimod-alpha-as-adjunctive-to-a-standard-chemotherapy-paclitaxel-metastatic-breast-carcinoma-34165https://curecurrent.com/trials/cyclin-dependent-kinase-in-triple-negative-breast-cancer-a-window-of-opportunity-study-34166https://curecurrent.com/trials/nsabp-biospecimen-discovery-project-34167https://curecurrent.com/trials/statewide-communication-to-reach-diverse-low-income-women-34168https://curecurrent.com/trials/dietary-intervention-and-brca-penetrance-34169https://curecurrent.com/trials/impact-of-acceptance-and-commitment-therapy-on-early-stage-breast-cancer-34170https://curecurrent.com/trials/correlation-between-pet-ct-parameters-and-tumor-markers-in-recurrent-breast-cancer-34171https://curecurrent.com/trials/football-fitness-after-breast-cancer-34172https://curecurrent.com/trials/cardiotoxicity-of-targeted-therapy-for-her-2-positive-breast-cancer-patients-at-high-altitude-34173https://curecurrent.com/trials/prognostic-value-of-circulating-tumor-dna-dosing-in-patients-in-neoadjuvant-breast-neoplasia-34174https://curecurrent.com/trials/optimizing-psychological-treatment-for-pain-after-breast-cancer-a-pilot-study-34175https://curecurrent.com/trials/collecting-analyzing-and-storing-samples-from-patients-with-metastatic-triple-negative-breast-cancer-receiving-anti-canc-34176https://curecurrent.com/trials/a-randomized-trial-of-letters-from-family-physicians-to-encourage-screening-mammography-in-overdue-women-34177https://curecurrent.com/trials/eribulin-as-1st-line-treatment-in-elderly-patients-with-advanced-breast-cancer-34178https://curecurrent.com/trials/neoadjuvant-gw572016-to-treat-breast-cancer-34179https://curecurrent.com/trials/anti-egfr-immunoliposomes-loaded-with-doxorubicin-in-patients-with-advanced-triple-negative-egfr-positive-breast-cancer-34180https://curecurrent.com/trials/place-of-comprehensive-geriatric-assessment-in-patients-75-years-care-with-breast-cancer-after-screening-with-fog-oncolo-34181https://curecurrent.com/trials/st-john-s-wort-in-relieving-hot-flashes-in-postmenopausal-women-with-non-metastatic-breast-cancer-34182https://curecurrent.com/trials/coenzyme-q10-in-relieving-treatment-related-fatigue-in-women-with-breast-cancer-34183https://curecurrent.com/trials/a-study-of-68ga-aby-025-pet-for-non-invasive-quantification-of-her2-expression-in-advanced-breast-cancer-34184https://curecurrent.com/trials/neoadjuvant-study-of-palbociclib-in-combination-with-letrozole-and-trastuzumab-in-stage-ii-iii-er-her2-breast-cancer-34185https://curecurrent.com/trials/palbociclib-letrozole-or-fulvestrant-in-african-american-women-with-hr-her2-breast-cancer-34186https://curecurrent.com/trials/memantine-hydrochloride-in-helping-cancer-survivors-stop-smoking-34187https://curecurrent.com/trials/fractional-co2-laser-therapy-versus-4-topical-lidocaine-gel-for-dyspareunia-in-breast-cancer-survivors-34188https://curecurrent.com/trials/characterization-of-neuromuscular-function-and-fatigue-after-breast-cancer-treated-with-adjuvant-chemotherapy-protect-04-34189https://curecurrent.com/trials/impact-of-novel-thoracic-wall-blocks-with-dexmetomidine-on-inflammatory-markers-following-breast-cancer-surgery-34190https://curecurrent.com/trials/feasibility-of-delivering-a-quitline-based-smoking-cessation-intervention-in-cancer-patients-34191https://curecurrent.com/trials/study-of-denosumab-as-adjuvant-treatment-for-women-with-high-risk-early-breast-cancer-receiving-neoadjuvant-or-adjuvant-34192https://curecurrent.com/trials/study-evaluating-bosutinib-letrozole-combination-versus-letrozole-alone-in-post-menopausal-women-with-breast-cancer-34193https://curecurrent.com/trials/dianaweb-before-and-after-study-online-based-participatory-research-on-breast-cancer-women-34194https://curecurrent.com/trials/pilot-study-to-evaluate-reparixin-with-weekly-paclitaxel-in-patients-with-her-2-negative-metastatic-breast-cancer-mbc-34195https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-proxalutamide-therapy-in-women-with-metastatic-breast-cancer-34196https://curecurrent.com/trials/the-psychology-of-chinese-breast-cancer-patients-34197https://curecurrent.com/trials/efficacy-of-everolimus-containing-chemotherapy-in-her2-mbc-patients-with-pi3k-akt-mtor-mutations-study-34198https://curecurrent.com/trials/improving-pre-operative-systemic-therapy-for-human-epidermal-growth-factor-receptor-2-her2-amplified-breast-cancer-34199https://curecurrent.com/trials/patient-report-outcome-and-oncological-safety-oncoplastic-and-conventional-bcs-cohort-34200https://curecurrent.com/trials/implication-of-metformin-plus-aromatase-inhibitor-in-obese-postmenopausal-breast-cancer-women-34201https://curecurrent.com/trials/a-trial-of-neoadjuvant-everolimus-plus-letrozole-versus-fec-in-women-with-er-positive-her2-negative-breast-cancer-34202https://curecurrent.com/trials/neoadjuvant-tdm1-with-lapatinib-and-abraxane-compared-with-trastuzumab-plus-pertuzumab-with-paclitaxel-34203https://curecurrent.com/trials/neo-adjuvant-study-in-triple-negative-breast-cancer-patients-34204https://curecurrent.com/trials/tak-228-plus-tamoxifen-in-patients-with-er-positive-her2-negative-breast-cancer-34205https://curecurrent.com/trials/neoadjuvant-study-of-sequential-eribulin-followed-by-fac-compared-to-sequential-paclitaxel-followed-by-fec-in-early-stag-34206https://curecurrent.com/trials/evaluation-of-geriatric-questionnaires-to-predict-toxicities-of-cdk-4-6-inhibitors-in-older-breast-cancer-patients-34207https://curecurrent.com/trials/neo-altto-neoadjuvant-lapatinib-and-or-trastuzumab-treatment-optimisation-study-34208https://curecurrent.com/trials/lapatinib-capecitabine-treatment-for-advanced-metastatic-breast-cancer-in-women-from-china-34209https://curecurrent.com/trials/effectiveness-of-compressive-bandage-use-in-seroma-prevention-34210https://curecurrent.com/trials/national-multicenter-pms-study-patient-reported-outcome-in-breast-reconstruction-following-mastectomy-with-tiloop-bra-34211https://curecurrent.com/trials/clinical-study-of-chidamide-combined-with-fulvestrant-in-the-treatment-of-hormone-receptor-positive-advanced-breast-canc-34212https://curecurrent.com/trials/genotype-and-phenotype-guided-supplementation-of-tamoxifen-standard-therapy-with-endoxifen-in-breast-cancer-patients-34213https://curecurrent.com/trials/a-study-evaluating-pertuzumab-perjeta-combined-with-trastuzumab-herceptin-and-standard-anthracycline-based-chemotherapy-34214https://curecurrent.com/trials/life-improved-by-exercise-live-trial-34215https://curecurrent.com/trials/a-study-of-hs-10342-in-chinese-patients-with-hr-her2-advanced-and-or-metastatic-breast-cancer-34216https://curecurrent.com/trials/metabolic-and-bone-changes-after-adjuvant-cancer-treatments-in-early-non-metastatic-breast-cancer-34217https://curecurrent.com/trials/effect-of-exercise-mode-in-breast-cancer-related-lymphedema-34218https://curecurrent.com/trials/hypofractionated-post-mastectomy-radiation-with-two-stage-expander-implant-reconstruction-34219https://curecurrent.com/trials/molecular-pathway-activation-markers-predicting-efficacy-of-trastuzumab-therapy-for-her2-positive-breast-cancer-34220https://curecurrent.com/trials/accuracy-of-vabb-elite-10g-versus-bard-14g-cnb-34221https://curecurrent.com/trials/haemocertm-application-in-breast-cancer-surgery-34222https://curecurrent.com/trials/robotic-versus-conventional-or-endoscopic-nipple-sparing-mastectomy-in-the-management-of-breast-cancer-prospective-study-34223https://curecurrent.com/trials/study-of-propranolol-in-newly-diagnosed-breast-cancer-patients-undergoing-neoadjuvant-chemotherapy-34224https://curecurrent.com/trials/trastuzumab-and-pertuzumab-in-combination-with-tocilizumab-in-subjects-with-metastatic-her2-positive-breast-cancer-resis-34225https://curecurrent.com/trials/melatonin-cream-against-acute-radiation-dermatitis-in-patients-with-early-breast-cancer-34226https://curecurrent.com/trials/evaluation-of-pembrolizumab-in-lymphopenic-metastatic-breast-cancer-patients-treated-with-metronomic-cyclophosphamide-34227https://curecurrent.com/trials/exercise-prescription-guided-by-heart-rate-variability-in-breast-cancer-patients-34228https://curecurrent.com/trials/wound-infections-in-breast-cancer-surgery-after-preoperative-skin-preparation-with-chlorhexidine-vs-povidone-iodine-34229https://curecurrent.com/trials/nivolumab-and-eribulin-in-her2-negative-metastatic-breast-cancer-34230https://curecurrent.com/trials/study-evaluating-efficacy-and-safety-of-sar566658-treatment-in-patients-with-ca6-positive-metastatic-triple-negative-bre-34231https://curecurrent.com/trials/registry-for-accelerated-partial-breast-irradiation-with-sbrt-or-imrt-34232https://curecurrent.com/trials/pbmt-for-the-prevention-of-cipn-34233https://curecurrent.com/trials/improving-access-to-control-of-diseases-for-women-34234https://curecurrent.com/trials/yttrium-y-90-resin-microspheres-data-collection-in-unresectable-liver-cancer-the-resin-study-34235https://curecurrent.com/trials/percutaneous-irreversible-electroportion-for-unresectable-breast-cancer-34236https://curecurrent.com/trials/delphinus-softvue-prospective-case-collection-arm-2-34237https://curecurrent.com/trials/a-single-arm-tolerability-and-safety-phase-iv-study-of-fulvestrant-faslodex-as-2nd-line-and-later-therapy-in-postmenopau-34238https://curecurrent.com/trials/testosterone-implants-and-the-incidence-of-breast-cancer-34239https://curecurrent.com/trials/adolescent-and-young-adult-cancer-patients-cognitive-toxicity-on-survivorship-acts-34240https://curecurrent.com/trials/cryotherapy-in-breast-b3-lesions-34241https://curecurrent.com/trials/delphinus-softvue-prospective-case-collection-arm-1-34242https://curecurrent.com/trials/optimizing-quality-of-life-in-women-living-with-metastatic-breast-cancer-34243https://curecurrent.com/trials/concordance-between-liquid-and-tissue-biopsy-34244https://curecurrent.com/trials/the-association-between-radiation-dermatitis-and-skin-microbiome-in-breast-cancer-patients-34245https://curecurrent.com/trials/get-real-and-heel-research-program-34246https://curecurrent.com/trials/exercise-program-of-breast-cancer-patients-undergoing-chemotherapy-with-or-without-radiation-34247https://curecurrent.com/trials/photobiomodulation-therapy-for-the-prevention-of-acute-radiodermatitis-in-breast-cancer-patients-undergoing-radiotherapy-34248https://curecurrent.com/trials/neobreads-neoadjuvant-breast-diet-study-34249https://curecurrent.com/trials/testing-a-culturally-adapted-telephone-genetic-counseling-intervention-34250https://curecurrent.com/trials/myhealth-follow-up-after-breast-cancer-treatment-34251https://curecurrent.com/trials/evaluation-of-hypothyroidism-incidence-after-breast-cancer-supraclavicular-irradiation-34252https://curecurrent.com/trials/establishment-and-clinical-application-of-precise-slnb-system-in-breast-cancer-a-randomized-multicenter-controlled-study-34253https://curecurrent.com/trials/a-study-of-ly3435151-in-participants-with-solid-tumors-34254https://curecurrent.com/trials/trial-with-eribulin-or-eribulin-endocrine-therapy-in-locally-recurrent-or-metastatic-breast-cancer-patients-34255https://curecurrent.com/trials/self-affirmation-construct-validity-34256https://curecurrent.com/trials/the-prone-to-supine-breast-mri-trial-34257https://curecurrent.com/trials/rehabilitation-after-breast-cancer-34258https://curecurrent.com/trials/promoting-early-detection-of-breast-cancer-in-rural-rwanda-impact-of-community-health-worker-and-nurse-training-34259https://curecurrent.com/trials/hypofractionation-with-simultaneous-integrated-boost-for-early-breast-cancer-34260https://curecurrent.com/trials/multicentric-study-for-external-validation-of-a-deep-learning-model-for-mammographic-breast-density-categorization-34261https://curecurrent.com/trials/pre-operative-non-anthracycline-chemotherapy-durvalumab-radiation-therapy-in-triple-negative-breast-cancer-34262https://curecurrent.com/trials/screening-plasma-her2-amplication-by-digital-pcr-in-advanced-breast-cancer-patients-treated-with-trastuzumab-and-pyrotin-34263https://curecurrent.com/trials/trial-of-diet-physical-activity-and-breast-cancer-recurrences-the-diana-5-study-34264https://curecurrent.com/trials/perioperative-oral-nutrition-supplementation-in-malnourished-surgical-cancer-patients-34265https://curecurrent.com/trials/cisplatin-rt-for-triple-negative-breast-cancer-34266https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-and-safety-of-different-forms-and-formulations-of-azd9496-in-healthy-subjects-34267https://curecurrent.com/trials/life-after-breast-cancer-impact-of-a-life-coach-34268https://curecurrent.com/trials/hypofractionated-versus-standard-fractionated-whole-breast-irradiation-to-node-negative-breast-cancer-patients-34269https://curecurrent.com/trials/clinical-investigation-to-evaluate-the-ability-of-mammowave-in-breast-lesions-detection-34270https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-combination-with-fulvestrant-compared-to-chemotherapy-in-women-with-hr-positive-her2-34271https://curecurrent.com/trials/investigating-the-long-term-cardiac-sequelae-of-trastuzumab-therapy-34272https://curecurrent.com/trials/prospective-multicenter-study-on-clinical-application-of-sonazoid-in-breast-tumor-34273https://curecurrent.com/trials/investigating-the-potential-role-of-a-novel-quadrate-combination-therapy-mifepristone-antiprogestrone-tamoxifen-retinoic-34274https://curecurrent.com/trials/autologous-fat-grafting-of-the-breast-in-women-with-post-lumpectomy-contour-defects-34275https://curecurrent.com/trials/novel-social-media-intervention-for-older-br-ca-patients-34276https://curecurrent.com/trials/breast-cancer-feasibility-of-an-educational-intervention-34277https://curecurrent.com/trials/safety-study-of-hmn14-to-treat-either-colorectal-or-breast-cancer-34278https://curecurrent.com/trials/expanded-access-for-immu-132-34279https://curecurrent.com/trials/chemotherapy-induced-cognitive-alterations-in-recruits-with-ovarian-and-breast-cancer-34280https://curecurrent.com/trials/phase-ii-study-of-immu-132-alone-or-in-combination-with-carboplatin-in-patients-with-triple-negative-breast-cancer-34281https://curecurrent.com/trials/insulin-sensitivity-after-breast-cancer-34282https://curecurrent.com/trials/a-window-of-opportunity-study-of-methionine-deprivation-in-triple-negative-breast-cancer-34283https://curecurrent.com/trials/pectoral-nerve-block-ii-and-erector-spine-plane-block-in-breast-cancer-surgery-34284https://curecurrent.com/trials/marginprobe-system-u-s-post-approval-study-34285https://curecurrent.com/trials/a-prospective-longitudinal-breast-cancer-study-34286https://curecurrent.com/trials/tumor-specific-plasma-dna-34287https://curecurrent.com/trials/a-yoga-program-for-breast-cancer-patients-undergoing-chemotherapy-34288https://curecurrent.com/trials/studying-tissue-samples-from-women-who-underwent-chemotherapy-for-lymph-node-positive-stage-ii-or-stage-iiia-breast-canc-34289https://curecurrent.com/trials/photobiomodulation-for-breast-cancer-radiodermatitis-34290https://curecurrent.com/trials/breast-cancer-omics-and-precision-medicine-34291https://curecurrent.com/trials/study-of-efficacy-safety-and-pharmacokinetics-of-fcn-437c-in-combination-with-fulvestrant-or-letrozole-goserelin-34292https://curecurrent.com/trials/study-of-sacituzumab-govitecan-hziy-immu-132-in-adults-with-epithelial-cancer-34293https://curecurrent.com/trials/efficacy-and-safety-of-dose-dense-chemotherapy-ddec-ddp-for-neoadjuvant-chemotherapy-of-her2-negative-breast-cancer-34294https://curecurrent.com/trials/tucidinostat-and-fulvestrant-in-hormone-receptor-positive-advanced-breast-cancer-34295https://curecurrent.com/trials/atezolizumab-and-cobimetinib-or-idasanutlin-in-participants-with-stage-iv-or-unresectable-recurrent-estrogen-receptor-po-34296https://curecurrent.com/trials/effects-of-infrared-laser-moxibustion-on-cancer-related-fatigue-in-breast-cancer-patients-34297https://curecurrent.com/trials/phase-ib-ii-study-of-mcs110-in-combination-with-pdr001-in-patients-with-advanced-malignancies-34298https://curecurrent.com/trials/covid-19-pandemic-effect-on-management-of-patients-with-breast-cancer-34299https://curecurrent.com/trials/the-effects-of-wheat-sprouts-supplements-on-the-key-health-indicators-of-the-patients-with-breast-cancer-after-chemother-34300https://curecurrent.com/trials/high-dose-vitamin-d-vs-standard-dose-vitamin-d-study-34301https://curecurrent.com/trials/canady-helios-cold-plasma-scalpel-treatment-at-the-surgical-margin-and-macroscopic-tumor-sites-34302https://curecurrent.com/trials/prevalence-of-lymphedema-in-valle-del-cauca-colombia-34303https://curecurrent.com/trials/imagio-feasibility-multi-reader-multi-case-study-34304https://curecurrent.com/trials/radiological-and-biological-tumoural-and-peri-tumoural-factors-in-neoadjuvant-endocrine-treated-breast-cancers-34305https://curecurrent.com/trials/a-pk-study-of-oraxol-in-breast-cancer-patients-34306https://curecurrent.com/trials/active-breathing-coordinator-based-vs-visionrt-based-deep-inspiration-breath-hold-for-radiation-for-breast-cancer-34307https://curecurrent.com/trials/circulating-tumor-cells-and-treatment-de-escalation-after-neoadjuvant-therapy-for-her2-positive-breast-cancer-34308https://curecurrent.com/trials/depression-and-body-image-distress-following-mastectomy-with-reconstruction-34309https://curecurrent.com/trials/spy-intra-operative-angiography-skin-perfusion-in-immediate-breast-reconstruction-w-implants-34310https://curecurrent.com/trials/experimental-study-about-physiotherapy-treatment-vs-self-treatment-in-axillary-web-syndrome-after-axillary-dissection-34311https://curecurrent.com/trials/tamoxifen-dose-adjustment-on-indonesian-female-er-breast-cancer-patients-based-on-cyp2d6-genotype-and-endoxifen-levels-34312https://curecurrent.com/trials/women-with-breast-cancer-undergoing-chemotherapy-implications-in-quality-of-life-34313https://curecurrent.com/trials/analyzing-the-composition-of-tears-to-identify-cancer-34314https://curecurrent.com/trials/exercise-and-tumor-blood-flow-in-lymphoma-and-breast-cancer-patients-exetumor-3-34315https://curecurrent.com/trials/sentinel-lymph-node-biopsy-in-breast-cancer-surgery-using-icg-34316https://curecurrent.com/trials/olaparib-and-radiotherapy-in-inoperable-breast-cancer-34317https://curecurrent.com/trials/hypofractionated-radiotherapy-concomitantly-with-weekly-boost-for-breast-cancer-patients-treated-with-conservative-breas-34318https://curecurrent.com/trials/treatment-after-palbociclib-containing-regimens-34319https://curecurrent.com/trials/the-role-of-magnetic-resonance-imaging-in-assessment-of-axillary-lymph-nodes-metastasis-in-breast-cancer-patients-34320https://curecurrent.com/trials/neoadjuvant-response-guided-treatment-of-luminal-b-type-tumors-and-luminal-a-type-tumors-with-node-metastases-34321https://curecurrent.com/trials/cinpt-in-autologous-abdominal-tissue-breast-reconstruction-34322https://curecurrent.com/trials/the-validation-of-sentinel-lymph-node-biopsy-after-neo-adjuvant-chemotherapy-in-breast-cancer-patients-34323https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-osseous-low-alpha-beta-resistant-metastases-for-pain-relief-34324https://curecurrent.com/trials/tesetaxel-plus-reduced-dose-of-capecitabine-in-patients-with-her2-negative-hr-positive-la-mbc-34325https://curecurrent.com/trials/tesetaxel-plus-3-different-pd-l-1-inhibitors-in-patients-with-triple-negative-mbc-and-tesetaxel-monotherapy-in-patients-34326https://curecurrent.com/trials/tesetaxel-plus-reduced-dose-of-capecitabine-vs-capecitabine-in-her2-negative-hr-positive-la-mbc-34327https://curecurrent.com/trials/aft-introduction-of-a-full-breast-reconstructive-method-34328https://curecurrent.com/trials/follow-up-of-early-breast-cancer-bc-patients-by-telephone-or-mobile-software-34329https://curecurrent.com/trials/palbociclib-in-premenopausal-women-with-er-positive-her-2-negative-metastatic-breast-cancer-34330https://curecurrent.com/trials/olanzapine-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting-in-chinese-breast-cancer-patients-34331https://curecurrent.com/trials/a-nutritional-intervention-and-physical-activity-program-reduce-body-weight-in-women-newly-diagnosed-with-breast-cancer-34332https://curecurrent.com/trials/auricular-point-acupressure-to-self-manage-chronic-pain-or-aromatase-inhibitor-musculoskeletal-symptoms-in-breast-cancer-34333https://curecurrent.com/trials/e-monitoring-of-patients-under-adjuvant-hormonotherapy-for-breast-cancer-34334https://curecurrent.com/trials/adcb-anlotinib-docetaxel-carboplatin-as-neoadjuvant-therapy-for-triple-negative-breast-cancer-34335https://curecurrent.com/trials/development-of-artificial-intelligence-system-for-detection-and-diagnosis-of-breast-lesion-using-mammography-34336https://curecurrent.com/trials/scalp-cooling-to-prevent-chemo-induced-hair-loss-34337https://curecurrent.com/trials/the-nutrinet-sant-study-34338https://curecurrent.com/trials/attitudes-toward-physical-activity-and-nutrition-intervention-during-cancer-treatment-34339https://curecurrent.com/trials/chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-metastatic-triple-negative-breast-cancer-34340https://curecurrent.com/trials/study-of-doxorubicin-in-patients-with-metastatic-breast-cancer-advanced-ovarian-cancer-34341https://curecurrent.com/trials/a-study-to-test-the-safety-and-effectiveness-of-nivolumab-combined-with-daratumumab-in-patients-with-pancreatic-non-smal-34342https://curecurrent.com/trials/safety-efficacy-of-q-122-in-breast-cancer-patients-taking-tamoxifen-or-aromatase-inhibitor-34343https://curecurrent.com/trials/non-hormonal-vaginal-moisturizer-in-hormone-receptor-positive-postmenopausal-cancer-survivors-experiencing-estrogen-depr-34344https://curecurrent.com/trials/trastuzumab-combined-with-pertuzumab-for-adjuvant-treatment-of-breast-cancer-after-neoadjuvant-therapy-34345https://curecurrent.com/trials/incagn01876-in-combination-with-immune-therapies-in-subjects-with-advanced-or-metastatic-malignancies-34346https://curecurrent.com/trials/recurindex-predicts-risk-of-recurrence-in-early-stage-luminal-breast-cancer-34347https://curecurrent.com/trials/expanded-access-with-abt-888-veliparib-to-treat-metastatic-breast-cancer-34348https://curecurrent.com/trials/oral-etoposide-combined-with-anlotinib-in-advanced-triple-negative-breast-cancer-34349https://curecurrent.com/trials/a-multicenter-open-and-observational-real-world-study-on-the-prognosis-and-treatment-in-young-women-with-breast-cancer-34350https://curecurrent.com/trials/the-effect-of-radiaace-gel-in-the-prevention-and-treatment-of-radiation-dermatitis-in-breast-cancer-patients-34351https://curecurrent.com/trials/nectar-everolimus-plus-cisplatin-in-triple-breast-cancer-34352https://curecurrent.com/trials/breast-mesh-used-in-two-staged-breast-reconstruction-34353https://curecurrent.com/trials/treatment-of-triple-negative-breast-cancer-with-albumin-bound-paclitaxel-as-neoadjuvant-therapy-a-prospective-rct-34354https://curecurrent.com/trials/study-for-the-knowledge-of-risk-factors-associated-with-breast-cancer-in-women-34355https://curecurrent.com/trials/persistant-post-mastectomy-pain-in-breast-cancer-incidence-and-risk-factors-34356https://curecurrent.com/trials/sj-subway-a-predictor-for-the-recurrence-of-high-risk-hormone-receptor-positive-breast-that-is-sensitive-to-extended-end-34357https://curecurrent.com/trials/palbociclib-letrozole-versus-epirubicin-cyclophosphamide-and-sequential-docetaxel-as-neoadjuvant-chemotherapy-34358https://curecurrent.com/trials/study-on-bisphosphonates-targeting-triple-negative-breast-cancer-34359https://curecurrent.com/trials/albumin-bound-paclitaxel-and-carboplatin-versus-epirubicin-and-docetaxel-for-triple-negative-breast-cancer-34360https://curecurrent.com/trials/palbociclib-combined-with-an-aromatase-inhibitor-in-breast-cancer-34361https://curecurrent.com/trials/diet-and-physical-activity-changes-among-latina-breast-cancer-survivors-34362https://curecurrent.com/trials/folate-receptor-alpha-peptide-vaccine-with-gm-csf-in-patients-with-triple-negative-breast-cancer-34363https://curecurrent.com/trials/managed-access-program-to-provide-alpelisib-for-patients-with-hr-advanced-or-metastatic-breast-cancer-34364https://curecurrent.com/trials/predictive-value-of-progastrin-titer-at-diagnosis-and-of-progastrin-kinetics-during-treatment-in-cancer-patients-34365https://curecurrent.com/trials/tumor-response-time-of-palbociclib-in-combination-with-ai-in-real-world-chinese-patients-34366https://curecurrent.com/trials/pyrotinib-and-vinorelbine-tartrate-capsules-with-or-without-inetetamab-for-first-line-treatment-in-patients-with-trastuz-34367https://curecurrent.com/trials/risk-assessment-model-of-trastuzumab-related-cardiotoxicity-in-breast-cancer-patients-34368https://curecurrent.com/trials/pcr-based-ceus-in-bi-rads-4a-nodules-34369https://curecurrent.com/trials/rws-of-inetetamab-her2-positive-advanced-breast-cancer-34370https://curecurrent.com/trials/phase-iv-trial-to-evaluate-breast-brachytherapy-using-the-mammosite-ml-34371https://curecurrent.com/trials/patient-reported-outcome-measurement-information-system-promis-physical-function-34372https://curecurrent.com/trials/prophylactic-irradiation-to-the-contralateral-breast-for-bcas-patients-34373https://curecurrent.com/trials/evaluation-of-heart-function-in-breast-cancer-patients-using-trastuzumab-34374https://curecurrent.com/trials/evaluation-of-the-immunological-effects-of-a-combined-treatment-with-radiation-and-cyclophosphamide-in-metastasized-brea-34375https://curecurrent.com/trials/optoacoustic-images-versus-imagio-ultrasound-34376https://curecurrent.com/trials/apatinib-in-neoadjuvant-therapy-for-patients-with-breast-cancer-34377https://curecurrent.com/trials/open-label-study-evaluating-the-safety-and-tolerability-of-ljm716-byl719-and-trastuzumab-in-patients-with-metastatic-her-34378https://curecurrent.com/trials/nab-paclitaxel-based-regimens-vs-paclitaxel-based-regimens-in-neoadjuvant-treatment-for-tnbc-34379https://curecurrent.com/trials/ph3-study-of-exemestane-with-or-without-entinostat-in-chinese-patients-with-hormone-receptor-positive-locally-advanced-o-34380https://curecurrent.com/trials/targeted-next-generation-sequencing-for-the-efficacy-of-trastuzumab-neoadjuvant-chemotherapy-in-breast-cancer-34381https://curecurrent.com/trials/hypofractionated-loco-regional-adjuvant-radiation-therapy-of-breast-cancer-combined-with-a-simultaneous-integrated-boost-34382https://curecurrent.com/trials/immunostimulating-interstitial-laser-thermotherapy-in-breast-cancer-34383https://curecurrent.com/trials/occupational-therapist-led-work-intervention-in-facilitating-work-maintenance-or-re-entry-to-the-workforce-in-patients-w-34384https://curecurrent.com/trials/a-study-of-pf-05280014-trastuzumab-pfizer-or-herceptin-trastuzumab-eu-plus-paclitaxel-in-her2-positive-first-line-metast-34385https://curecurrent.com/trials/inetetamab-plus-cyclophosphamide-metronomic-chemotherapy-plus-aromatase-inhibitor-in-metastatic-her2-hr-breast-cancer-34386https://curecurrent.com/trials/molecular-genetic-basis-of-invasive-breast-cancer-risk-associated-with-lobular-carcinoma-in-situ-34387https://curecurrent.com/trials/a-study-of-ak-01-ly3295668-in-solid-tumors-34388https://curecurrent.com/trials/s0307-phase-iii-trial-of-bisphosphonates-as-adjuvant-therapy-for-primary-breast-cancer-34389https://curecurrent.com/trials/a-pilot-study-to-investigate-the-effect-of-cytotoxic-therapy-and-or-radiotherapy-on-cancer-related-sleep-disturbances-in-34390https://curecurrent.com/trials/single-arm-phase-ii-study-of-fractionated-stereotatic-radiation-therapy-fsrt-for-bone-metastases-in-breast-cancer-34391https://curecurrent.com/trials/f-18-fes-pet-ct-in-measuring-hormone-expression-in-patients-with-primary-recurrent-or-metastatic-breast-cancer-undergoin-34392https://curecurrent.com/trials/study-of-m4344-in-combination-with-niraparib-34393https://curecurrent.com/trials/pembrolizumab-and-paclitaxel-in-hormone-receptor-positive-hypermutatted-metastatic-breast-cancer-identified-by-whole-exo-34394https://curecurrent.com/trials/real-time-diagnosis-and-visualization-of-tumor-margins-in-excised-breast-specimens-using-zenith-flim-diagnostics-34395https://curecurrent.com/trials/comparison-of-bi-level-erector-spine-plane-block-and-combined-pectoral-i-ii-block-in-breast-surgery-34396https://curecurrent.com/trials/laser-optoacoustic-and-ultrasonic-imaging-system-assembly-in-finding-changes-in-tumors-in-patients-with-breast-cancer-34397https://curecurrent.com/trials/study-of-the-efficacy-of-chloroquine-in-the-treatment-of-ductal-carcinoma-in-situ-the-pinc-trial-34398https://curecurrent.com/trials/treatment-of-breast-cancer-related-lymphedema-with-stem-cells-and-fat-grafting-34399https://curecurrent.com/trials/retrospective-comparative-in-vitro-case-controlled-study-of-the-liquid-biopsy-test-system-in-women-with-breast-cancer-34400https://curecurrent.com/trials/prevention-of-breast-cancer-related-lymphedma-with-tacrolimus-34401https://curecurrent.com/trials/assessment-of-health-related-quality-of-life-in-women-who-underwent-breast-reconstruction-after-radical-surgery-34402https://curecurrent.com/trials/interventional-study-on-the-impact-of-the-hypnosis-used-as-sedation-or-relaxation-in-the-breast-oncologic-surgery-34403https://curecurrent.com/trials/optional-sub-study-to-intraoperative-imaging-with-icg-registry-34404https://curecurrent.com/trials/liposuction-for-arm-lymphedema-following-breast-cancer-surgery-34405https://curecurrent.com/trials/fulvestrant-plus-anlotinib-in-hr-her2-metastatic-breast-cancer-with-fgfr-mutation-34406https://curecurrent.com/trials/hypofractionated-radiation-therapy-in-patients-with-breast-cancer-34407https://curecurrent.com/trials/evaluation-of-two-boost-radiation-schedules-in-post-lumpectomy-early-stage-carcinoma-breast-34408https://curecurrent.com/trials/bone-loss-treatment-from-adjuvant-zoledronate-efficacy-34409https://curecurrent.com/trials/hypnosis-to-reduce-aromatase-inhibitor-pain-and-improve-adherence-34410https://curecurrent.com/trials/contrast-enhanced-ultrasonography-combined-with-blue-dye-as-dual-tracer-for-sentinel-lymph-node-biopsy-34411https://curecurrent.com/trials/epicutaneous-cryoimmunotherapy-combined-with-pembrolizumab-for-cutaneous-metastatic-breast-cancer-34412https://curecurrent.com/trials/efficacy-study-of-mcs110-given-with-carboplatin-and-gemcitabine-in-advanced-triple-negative-breast-cancer-tnbc-34413https://curecurrent.com/trials/exercise-regimen-designed-to-improve-functional-mobility-body-composition-and-strength-after-breast-conservation-therapy-34414https://curecurrent.com/trials/randomized-controlled-trial-with-hybrid-fractional-laser-34415https://curecurrent.com/trials/a-study-of-gdc-0810-single-agent-or-in-combination-with-palbociclib-and-or-a-luteinizing-hormone-releasing-hormone-lhrh-34416https://curecurrent.com/trials/can-her2-targeted-pet-ct-imaging-identify-unsuspected-her2-positive-breast-cancer-metastases-which-are-amenable-to-her2-34417https://curecurrent.com/trials/assessment-of-safety-and-efficacy-of-estetrol-in-postmenopausal-women-with-advanced-estrogen-receptor-positive-er-breast-34418https://curecurrent.com/trials/added-value-of-contrast-enhanced-ultrasound-for-bi-rads-4a-nodules-34419https://curecurrent.com/trials/pyrotinib-plus-vinorelbine-in-her2-metastatic-breast-cancer-patients-34420https://curecurrent.com/trials/ribociclib-endocrine-combination-therapy-versus-chemotherapy-as-1st-line-in-visceral-mbc-34421https://curecurrent.com/trials/circulating-fetal-cells-and-breast-cancer-34422https://curecurrent.com/trials/aspen-ultrasound-system-and-aspen-rehabilitation-technique-in-the-treatment-of-capsular-contracture-34423https://curecurrent.com/trials/immunogenicity-assessment-of-peg-filgrastim-vs-neulasta-as-adjunct-to-chemotherapy-in-patients-with-breast-cancer-34424https://curecurrent.com/trials/prospective-evaluation-of-breast-cancer-at-brazilian-institutions-project-amazona-iii-34425https://curecurrent.com/trials/pilates-and-dance-to-breast-cancer-patients-undergoing-treatment-34426https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-of-margetuximab-in-chinese-patients-with-her2-mbc-34427https://curecurrent.com/trials/study-evaluating-the-effects-of-neratinib-after-adjuvant-trastuzumab-in-women-with-early-stage-breast-cancer-34428https://curecurrent.com/trials/effects-of-gnrha-on-ovarian-function-against-chemotherapy-induced-gonadotoxicity-34429https://curecurrent.com/trials/understanding-barriers-to-initiation-and-adherence-to-endocrine-therapy-in-young-breast-cancer-survivors-of-diverse-back-34430https://curecurrent.com/trials/study-of-avb-620-in-women-with-primary-nonrecurrent-breast-cancer-undergoing-surgery-34431https://curecurrent.com/trials/eribulin-treatment-as-1st-line-or-2nd-line-chemotherapy-for-her2-negative-hormone-resistant-inoperable-or-recurrent-meta-34432https://curecurrent.com/trials/a-study-of-neratinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-in-patients-with-her2-metastatic-breast-cancer-34433https://curecurrent.com/trials/augmented-reality-ar-the-future-of-patient-information-leaflets-34434https://curecurrent.com/trials/stage-i-her2-positive-invasive-breast-cancer-de-escalation-study-iris-c-d-34435https://curecurrent.com/trials/rheumatological-evaluation-of-anastrozole-and-letrozole-as-adjuvant-treatment-in-post-menopausal-women-with-breast-cance-34436https://curecurrent.com/trials/efficacy-of-anastrozole-and-fulvestrant-in-patients-with-er-positive-her2-negative-operable-breast-cancer-34437https://curecurrent.com/trials/pre-operative-hypnosis-to-prevent-side-effects-after-surgery-34438https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-rucaparib-in-metastatic-breast-cancer-patients-with-a-brcaness-genomic-signature-34439https://curecurrent.com/trials/effects-of-meditative-movement-qigong-tai-chi-easy-on-fatigued-breast-cancer-survivors-34440https://curecurrent.com/trials/the-efficacy-and-safety-of-neoadjuvant-trastuzumab-plus-taxane-with-and-without-pertuzumab-therapy-34441https://curecurrent.com/trials/assessing-the-impact-of-electronic-capture-of-patient-reported-outcomes-in-radiation-oncology-34442https://curecurrent.com/trials/pilot-clinical-study-on-a-low-power-electromagnetic-wave-breast-imaging-device-for-cancer-screening-purposes-34443https://curecurrent.com/trials/tislelizumab-in-combination-with-eribulin-for-patients-with-metastatic-previously-heavily-treated-triple-negative-breast-34444https://curecurrent.com/trials/pecs-2-for-breast-surgery-34445https://curecurrent.com/trials/pyrotinib-as-neoadjuvant-agent-for-non-objective-response-her2-positive-early-breast-cancer-34446https://curecurrent.com/trials/a-study-of-shr6390-in-combination-with-fulvestrant-in-patients-with-hr-positive-and-her2-negative-advanced-breast-cancer-34447https://curecurrent.com/trials/trajectory-analysis-of-symptom-distress-and-cancer-related-fatigue-after-adjuvant-chemotherapy-in-breast-cancer-female-34448https://curecurrent.com/trials/establishing-the-recommended-biological-dose-for-ae37-peptide-vaccine-in-combination-with-pembrolizumab-that-will-enhanc-34449https://curecurrent.com/trials/a-study-of-shr6390-in-combination-with-letrozole-or-anastrozole-in-patients-with-hr-positive-and-her2-negative-advanced-34450https://curecurrent.com/trials/concomitant-and-sequential-radiohormonotherapy-in-adjuvant-breast-cancer-34451https://curecurrent.com/trials/a-multicenter-prospective-post-registration-study-of-empegfilgrastim-to-evaluate-safety-and-efficacy-in-special-cancer-p-34452https://curecurrent.com/trials/tkis-vs-pertuzumab-in-her2-breast-cancer-patients-with-active-brain-metastases-her2brain-34453https://curecurrent.com/trials/health-related-quality-of-life-coupled-with-therapeutic-information-on-compliance-to-endocrine-therapy-in-breast-cancer-34454https://curecurrent.com/trials/clinical-evaluation-of-a-novel-wearable-compression-technology-in-the-treatment-of-lymphedema-an-open-label-controlled-s-34455https://curecurrent.com/trials/the-beacon-study-breast-cancer-outcomes-with-nktr-102-34456https://curecurrent.com/trials/study-of-camrelizumab-plus-chemotherapy-as-neoadjuvant-therapy-in-participants-with-triple-negative-breast-cancer-tnbc-34457https://curecurrent.com/trials/reverse-axillary-mapping-in-breast-radiation-treatment-planning-34458https://curecurrent.com/trials/single-dose-pharmacokinetic-study-of-gb221-in-comparison-with-herceptin-34459https://curecurrent.com/trials/preoperative-cisplatin-and-bevacizumab-in-er-pr-her2-negative-breast-cancer-34460https://curecurrent.com/trials/phase-ii-trial-of-neoadjuvant-metronomic-chemotherapy-in-triple-negative-breast-cancer-34461https://curecurrent.com/trials/s-81694-plus-paclitaxel-in-metastatic-breast-cancer-34462https://curecurrent.com/trials/a-pilot-multi-institutional-study-to-evaluate-the-accuracy-of-a-breast-cancer-locator-in-patients-with-palpable-cancers-34463https://curecurrent.com/trials/molecular-evaluation-in-metastatic-breast-cancer-34464https://curecurrent.com/trials/implementation-of-a-web-based-decision-aid-for-breast-cancer-surgery-34465https://curecurrent.com/trials/pyrotinib-versus-pertuzumab-in-combination-with-neoadjuvant-trastuzumab-and-nab-paclitaxel-in-her2-early-or-locally-adva-34466https://curecurrent.com/trials/rollover-study-of-weekly-paclitaxel-bms-181339-in-patients-with-advanced-breast-cancer-34467https://curecurrent.com/trials/evaluation-of-an-anti-cancer-immunotherapy-combined-with-standard-neoadjuvant-treatment-in-patients-with-wt1-positive-pr-34468https://curecurrent.com/trials/development-of-a-patient-decision-aid-for-women-considering-breast-reconstruction-34469https://curecurrent.com/trials/physiotherapy-program-for-breast-cancer-women-following-surgery-a-pilot-clinical-trial-34470https://curecurrent.com/trials/effectiveness-of-ear-acupuncture-to-improve-insomnia-in-women-with-breast-cancer-34471https://curecurrent.com/trials/treatment-with-pyrotinib-based-therapy-in-lapatinib-resistant-her2-positive-metastatic-breast-cancer-34472https://curecurrent.com/trials/study-of-isb-1302-cd3-bispecific-ab-in-her2-positive-metastatic-breast-cancer-34473https://curecurrent.com/trials/analgesic-effect-of-adding-thoracic-paravertebral-nerve-blocks-to-modified-pec-block-in-breast-cancer-surgery-34474https://curecurrent.com/trials/neozol-follow-up-study-34475https://curecurrent.com/trials/plasma-circulating-tumor-dna-analyses-in-er-metastatic-breast-cancer-34476https://curecurrent.com/trials/intravenous-chemotherapy-and-plant-based-dietary-supplements-34477https://curecurrent.com/trials/eribulin-combined-with-anlotinib-in-metastatic-her2-negative-breast-cancer-34478https://curecurrent.com/trials/modified-pectoral-nerve-block-versus-serratus-plane-block-34479https://curecurrent.com/trials/cabozantinib-trastuzumab-in-breast-cancer-patients-w-brain-metastases-34480https://curecurrent.com/trials/plant-sterol-intervention-for-cancer-prevention-pinc-34481https://curecurrent.com/trials/tocotrienol-in-combination-with-neoadjuvant-chemotherapy-for-women-with-breast-cancer-34482https://curecurrent.com/trials/a-non-randomized-open-label-study-to-evaluate-the-safety-and-effectiveness-of-the-dayspring-technology-for-patients-with-34483https://curecurrent.com/trials/examination-of-breast-cancer-cells-of-pre-menopausal-and-post-menopausal-women-before-and-after-exposure-to-tamoxifen-or-34484https://curecurrent.com/trials/partial-breast-irradiation-using-non-invasive-approach-for-early-stage-breast-cancer-34485https://curecurrent.com/trials/predicting-response-of-metastatic-triple-negative-breast-cancer-to-immunotherapy-based-on-patients-cytokine-profile-34486https://curecurrent.com/trials/effect-of-pembrolizumab-keytruda-on-biomarkers-in-early-breast-cancer-34487https://curecurrent.com/trials/her-seq-a-blood-based-screening-study-to-identify-patients-with-her2-mutations-for-enrollment-into-clinical-research-stu-34488https://curecurrent.com/trials/miami-safe-surgery-for-multiple-breast-cancers-34489https://curecurrent.com/trials/in-vitro-study-of-the-liquid-biopsy-test-system-of-the-diagnostic-value-in-women-with-various-forms-of-breast-cancer-34490https://curecurrent.com/trials/grape-juice-and-dermatitis-in-breast-cancer-34491https://curecurrent.com/trials/abexinostat-palbociclib-and-fulvestrant-for-the-treatment-of-breast-or-gynecologic-cancer-34492https://curecurrent.com/trials/preoperative-dose-dense-doxorubicin-and-cyclophosphamide-followed-by-paclitaxel-with-bevacizumab-in-operable-breast-canc-34493https://curecurrent.com/trials/efficacy-and-safety-of-leuprorelin-3m-in-premenopausal-women-with-hormone-receptor-positive-breast-cancer-34494https://curecurrent.com/trials/tahini-and-dermatitis-in-breast-cancer-34495https://curecurrent.com/trials/immediate-breast-reconstruction-s-increasing-34496https://curecurrent.com/trials/prems-on-proms-in-breast-disease-prems-proms-34497https://curecurrent.com/trials/women-underwent-tram-surgery-its-influence-on-abdominal-muscle-function-and-the-effects-of-therapeutic-exercises-34498https://curecurrent.com/trials/heat-shock-protein-hsp-70-to-quantify-and-characterize-circulating-tumor-cells-34499https://curecurrent.com/trials/safety-feasibility-and-efficacy-of-vitamin-d-supplementation-in-women-with-metastatic-breast-cancer-safe-d-34500https://curecurrent.com/trials/fulvestrant-plus-enzalutamide-in-er-her2-advanced-breast-cancer-34501https://curecurrent.com/trials/pilot-study-to-evaluate-safety-biological-effects-of-orally-administered-reparixin-in-early-breast-cancer-34502https://curecurrent.com/trials/dynamics-and-tracer-distribution-of-tilmanocept-in-early-stage-breast-cancer-34503https://curecurrent.com/trials/breast-cancers-risk-factors-among-mexican-women-in-mexico-mexican-american-and-african-american-women-in-the-u-s-34504https://curecurrent.com/trials/aromatase-inhibitor-host-factors-study-34505https://curecurrent.com/trials/effect-of-telemonitoring-on-functionality-quality-of-life-and-risk-of-lymphedema-in-breast-cancer-survivors-34506https://curecurrent.com/trials/safety-and-preliminary-efficacy-of-snk01-in-combination-with-trastuzumab-or-cetuximab-in-subjects-with-advanced-her2-or-34507https://curecurrent.com/trials/reducing-breast-cancer-related-fatigue-and-improving-cognition-with-non-invasive-brain-stimulation-34508https://curecurrent.com/trials/mathematical-modeling-to-predict-response-to-neoadjuvant-chemotherapy-in-breast-cancer-34509https://curecurrent.com/trials/compass-course-efficacy-study-34510https://curecurrent.com/trials/comparison-of-mri-with-pet-ct-in-the-evaluation-of-response-to-neoadjuvant-therapy-based-on-the-molecular-subtypes-of-br-34511https://curecurrent.com/trials/intraoperative-tissue-identification-by-analyzing-surgical-smoke-34512https://curecurrent.com/trials/dietary-seaweed-and-early-breast-cancer-a-randomized-trial-34513https://curecurrent.com/trials/chemoprevention-trial-anastrozole-in-ductal-carcinoma-in-situ-dcis-in-postmenopausal-women-34514https://curecurrent.com/trials/neoadjuvant-study-of-two-platinum-regimens-in-triple-negative-breast-cancer-34515https://curecurrent.com/trials/personalized-vaccine-for-cancer-immunotherapy-34516https://curecurrent.com/trials/to-compare-zoladex-10-8-mg-with-zoladex-3-6mg-in-chinese-pre-menopausal-er-her2-early-breast-cancer-34517https://curecurrent.com/trials/indocyanine-green-fluorescence-guided-sentinel-node-biopsy-in-breast-cancer-within-a-north-african-population-a-retrospe-34518https://curecurrent.com/trials/cd133-expression-in-mammary-invasive-ductal-carcinoma-34519https://curecurrent.com/trials/effects-of-aromatase-inhibitor-therapy-on-muscle-function-34520https://curecurrent.com/trials/bevacizumab-etoposide-and-cisplatin-followed-by-whole-brain-radiotherapy-in-breast-cancer-with-brain-metastases-34521https://curecurrent.com/trials/prospective-assessment-of-quality-of-life-in-patients-with-locally-recurrent-breast-cancer-and-hyperthermic-radiotherapy-34522https://curecurrent.com/trials/hypofractionated-radiotherapy-in-breast-cancer-34523https://curecurrent.com/trials/a-pilot-study-of-ga-68-psma-pet-mri-for-the-assessment-of-psma-positive-tumors-34524https://curecurrent.com/trials/warm-acupuncture-for-breast-cancer-related-lymphedema-34525https://curecurrent.com/trials/study-of-isu104-targeting-erbb3-in-patients-with-advanced-solid-tumors-34526https://curecurrent.com/trials/azd5153-in-patients-with-relapsed-or-refractory-solid-tumors-including-lymphomas-34527https://curecurrent.com/trials/implementation-of-a-cdss-in-oncology-patients-during-covid-19-34528https://curecurrent.com/trials/placebo-controlled-trial-of-f-627-in-women-with-breast-cancer-receiving-myelotoxic-chemotherapy-34529https://curecurrent.com/trials/emotional-security-and-quality-of-life-among-breast-cancer-patient-who-have-undergo-mastectomy-34530https://curecurrent.com/trials/study-of-ribociclib-with-everolimus-exemestane-in-hr-her2-locally-advanced-metastatic-breast-cancer-post-progression-on-34531https://curecurrent.com/trials/observational-study-of-pertuzumab-safety-in-participants-with-breast-cancer-34532https://curecurrent.com/trials/objective-evaluation-of-paclitaxel-docetaxel-induced-neuropathy-in-breast-cancer-patients-34533https://curecurrent.com/trials/adjuvant-endocrine-therapy-in-early-stage-breast-cancer-adherence-and-clinical-outcome-34534https://curecurrent.com/trials/a-first-in-man-phase-i-ii-study-of-oral-onc201-in-patients-with-advanced-cancer-34535https://curecurrent.com/trials/living-better-with-advanced-breast-cancer-feasibility-evaluation-of-an-online-supportive-intervention-34536https://curecurrent.com/trials/aerobic-training-in-treatment-for-breast-cancer-34537https://curecurrent.com/trials/feasibility-and-safety-of-caremin650-in-patients-at-risk-of-or-suffering-from-oral-mucositis-and-or-radiation-dermatitis-34538https://curecurrent.com/trials/genetic-neurophysiological-and-psychological-risk-factors-for-neuropathic-pain-34539https://curecurrent.com/trials/presentation-of-first-time-attenders-at-lymphedema-clinics-34540https://curecurrent.com/trials/sentinel-node-after-neoadjuvancy-in-node-positive-breast-cancer-34541https://curecurrent.com/trials/randomized-trial-of-eonconote-34542https://curecurrent.com/trials/carboplatin-abraxane-avastin-as-neoadjuvant-therapy-for-her2-negative-breast-cancer-34543https://curecurrent.com/trials/doxorubicin-and-cyclophosphamide-plus-paclitaxel-with-or-without-trastuzumab-in-treating-women-with-node-positive-breast-34544https://curecurrent.com/trials/pilot-syndros-decreasing-use-of-opioids-in-breast-cancer-subjects-with-bone-mets-34545https://curecurrent.com/trials/involvement-of-sk3-calcium-channel-in-taxane-neuropathy-34546https://curecurrent.com/trials/tomosymthesis-for-breast-mass-lesion-characterization-34547https://curecurrent.com/trials/a-safety-and-tolerability-study-of-assisted-and-self-administered-subcutaneous-sc-herceptin-trastuzumab-as-adjuvant-ther-34548https://curecurrent.com/trials/phase-ii-pembrolizumab-palliative-radiotherapy-in-bc-34549https://curecurrent.com/trials/adjuvant-radiotherapy-on-circulating-cells-in-breast-cancer-patients-34550https://curecurrent.com/trials/improving-food-pleasure-and-intake-of-oncology-patients-receiving-chemotherapy-34551https://curecurrent.com/trials/the-role-of-supar-biomarker-in-blood-samples-of-breast-cancer-patients-during-and-post-doxorubicin-chemotherapy-causativ-34552https://curecurrent.com/trials/application-enabled-shared-decision-making-34553https://curecurrent.com/trials/neoadjuvant-treatment-with-palbociclib-and-exemestane-plus-trastuzumab-and-pyrotinib-in-estrogen-receptor-er-positive-he-34554https://curecurrent.com/trials/efficacy-of-expressive-writing-on-quality-of-life-among-breast-cancer-survivors-in-oman-a-double-blind-randomized-contro-34555https://curecurrent.com/trials/study-of-cyh33-in-combination-with-endocrine-therapy-with-or-without-palbociclib-in-patients-with-hr-her2-advanced-breas-34556https://curecurrent.com/trials/a-study-of-gdc-0810-versus-fulvestrant-in-postmenopausal-women-with-advanced-or-metastatic-breast-cancer-resistant-to-ar-34557https://curecurrent.com/trials/therapeutic-exercise-in-cancer-related-fatigue-in-women-after-breast-cancer-treatment-34558https://curecurrent.com/trials/analysis-of-therapy-sequence-in-women-with-hr-her2-mbc-in-moscow-a-multicenter-retrospective-observational-study-34559https://curecurrent.com/trials/mobile-app-postoperative-home-monitoring-after-enhanced-recovery-oncologic-surgery-34560https://curecurrent.com/trials/ruxolitinib-w-preop-chemo-for-triple-negative-inflammatory-brca-34561https://curecurrent.com/trials/multi-beam-intensity-modulated-radiation-therapy-for-node-positive-breast-cancer-34562https://curecurrent.com/trials/ultrasound-guided-rhomboid-intercostal-and-subserratus-plane-block-in-breast-cancer-surgeries-34563https://curecurrent.com/trials/web-based-decision-aid-in-improving-informed-decisions-in-patients-with-stage-0-iiia-breast-cancer-considering-contralat-34564https://curecurrent.com/trials/comparison-of-erector-spina-plane-block-and-thoracic-epidural-block-34565https://curecurrent.com/trials/monoclonal-antibodies-elimination-in-breast-cancer-patient-34566https://curecurrent.com/trials/breast-cancer-axillary-conservation-after-neoadjuvant-chemotherapy-in-micro-metastatic-sentinel-lymph-nodes-34567https://curecurrent.com/trials/predicting-neoadjuvant-chemotherapy-response-by-using-a-combined-mri-and-scinti-mammography-mri-smm-system-34568https://curecurrent.com/trials/safety-of-the-use-of-compressive-taping-in-seroma-34569https://curecurrent.com/trials/3d-printed-bolus-in-post-mastectomy-radiotherapy-34570https://curecurrent.com/trials/decision-support-for-brca-testing-in-ethnically-diverse-women-34571https://curecurrent.com/trials/study-of-paclitaxel-in-combination-with-bos172722-in-patients-with-advanced-nonhaematologic-malignancies-34572https://curecurrent.com/trials/mat-pilates-in-women-with-breast-cancer-during-adjuvant-radiotherapy-34573https://curecurrent.com/trials/effects-of-riluzole-on-cns-glutamate-and-fatigue-in-breast-cancer-survivors-with-high-inflammation-34574https://curecurrent.com/trials/quantitative-analysis-of-outcomes-in-breast-reconstruction-34575https://curecurrent.com/trials/a-trial-of-standard-chemotherapy-with-metformin-vs-placebo-in-women-with-metastatic-breast-cancer-34576https://curecurrent.com/trials/comparison-of-patient-reported-outcome-measures-using-the-breast-q-questionnaire-in-patients-undergoing-pre-versus-sub-p-34577https://curecurrent.com/trials/therapy-with-bevacizumab-bev-doxorubicin-and-cyclophosphamide-followed-by-bev-docetaxel-and-capecitabine-before-surgery-34578https://curecurrent.com/trials/reducing-sedentary-behaviour-with-technology-34579https://curecurrent.com/trials/diffusion-tensor-breast-mri-dti-34580https://curecurrent.com/trials/phase-ib-trial-of-lee011-with-everolimus-rad001-and-exemestane-in-the-treatment-of-hormone-receptor-positive-her2-negati-34581https://curecurrent.com/trials/comparison-of-digital-breast-tomosynthesis-to-conventional-mammography-34582https://curecurrent.com/trials/ehealth-weight-loss-program-in-african-american-breast-cancer-survivors-34583https://curecurrent.com/trials/a-study-to-assess-how-itraconazole-affects-the-uptake-and-elimination-of-capivasertib-in-the-body-34584https://curecurrent.com/trials/anxiety-on-the-first-day-of-chemotherapy-34585https://curecurrent.com/trials/quantification-of-breast-sensation-following-postmastectomy-breast-reconstruction-34586https://curecurrent.com/trials/selective-axillary-lymph-node-dissection-vs-complete-axillary-dissection-a-randomised-clinical-trial-to-assess-the-preve-34587https://curecurrent.com/trials/neoadjuvant-pembrolizumab-pbr-nab-paclitaxel-followed-by-pbr-epirubicin-cyclophosphamide-in-tnbc-34588https://curecurrent.com/trials/lifestyles-of-health-and-sustainability-for-breast-cancer-survivors-34589https://curecurrent.com/trials/an-intimacy-intervention-for-couples-completing-breast-or-prostate-cancer-34590https://curecurrent.com/trials/acceptance-and-commitment-therapy-in-improving-well-being-in-patients-with-stage-iii-iv-cancer-and-their-partners-34591https://curecurrent.com/trials/breast-cancer-survivors-main-physical-and-psychosocial-problems-after-completion-of-treatment-34592https://curecurrent.com/trials/effect-of-information-about-the-benefits-and-harms-of-mammography-on-women-s-decision-making-34593https://curecurrent.com/trials/adjuvant-chemotherapy-with-epirubicin-cmf-and-weekly-docetaxel-or-weekly-paclitaxel-in-patients-with-resected-high-risk-34594https://curecurrent.com/trials/loreline-study-characterization-of-long-responders-under-eribuline-34595https://curecurrent.com/trials/ce-mri-cesm-in-solid-breast-lesions-34596https://curecurrent.com/trials/high-intensity-interval-training-for-stage-i-iii-breast-cancer-patients-34597https://curecurrent.com/trials/compression-garments-in-breast-cancer-related-lymphedema-34598https://curecurrent.com/trials/validation-of-a-screening-tool-in-geriatric-oncology-34599https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-indian-patients-with-human-epidermal-growth-factor-receptor-2-her2-positive-unresect-34600https://curecurrent.com/trials/pectoral-nerve-block-type-ii-and-rhomboid-intercostal-block-for-pain-management-following-mastectomy-surgery-34601https://curecurrent.com/trials/study-of-azacitidine-and-durvalumab-in-advanced-solid-tumors-34602https://curecurrent.com/trials/breast-cancer-endocrine-therapy-fitness-be-fit-trial-34603https://curecurrent.com/trials/radiation-therapy-for-ypn0-breast-cancer-34604https://curecurrent.com/trials/microwave-ablation-of-breast-tumors-34605https://curecurrent.com/trials/clinical-study-of-vascular-imaging-evaluation-of-computed-tomography-photoacoustic-breast-imaging-system-34606https://curecurrent.com/trials/shorter-scalp-cooling-time-in-paclitaxel-34607https://curecurrent.com/trials/progressive-relaxation-training-in-breast-cancer-patients-receiving-aromatatase-inhibitor-therapy-34608https://curecurrent.com/trials/hypofractionation-and-ultra-hypofractionation-in-adjuvant-radiotherapy-for-breast-cancer-34609https://curecurrent.com/trials/study-on-classification-method-of-indocyanine-green-lymphography-based-on-deep-learning-34610https://curecurrent.com/trials/neoadjuvant-therapy-study-guided-by-drug-screening-in-vitro-for-her2-positive-early-breast-cancer-patients-34611https://curecurrent.com/trials/trastuzumab-pertuzumab-followed-by-t-dm1-in-mbc-34612https://curecurrent.com/trials/lisinopril-or-coreg-cr-in-reducing-side-effects-in-women-with-breast-cancer-receiving-trastuzumab-34613https://curecurrent.com/trials/a-study-of-imp4297-in-patients-with-advanced-solid-tumors-34614https://curecurrent.com/trials/randomized-double-blind-multicenter-phase-ii-study-of-time-to-progression-on-fulvestrant-in-combination-with-erlotinib-o-34615https://curecurrent.com/trials/the-safety-and-pharmacokinetics-of-imp4297-in-patients-with-advanced-solid-tumors-34616https://curecurrent.com/trials/does-a-preoperative-prophylactic-antibiotic-reduce-surgical-site-infection-following-wire-localized-lumpectomy-34617https://curecurrent.com/trials/adherence-of-hispanic-latina-breast-cancer-patients-to-adjuvant-aromatase-inhibitors-34618https://curecurrent.com/trials/safety-and-efficacy-of-rad001-everolimus-in-combination-with-letrozole-in-the-treatment-of-postmenopausal-women-with-loc-34619https://curecurrent.com/trials/evaluation-of-the-effect-of-mediterranean-diet-on-breast-cancer-patients-34620https://curecurrent.com/trials/long-term-outcomes-after-breast-cancer-liver-metastasis-surgery-an-european-retrospective-snapshot-study-34621https://curecurrent.com/trials/application-of-deep-learning-and-ultrasound-elastography-in-opportunistic-screening-of-breast-cancer-34622https://curecurrent.com/trials/t-cell-receptor-immunotherapy-targeting-ny-eso-1-for-patients-with-ny-eso-1-expressing-cancer-34623https://curecurrent.com/trials/breast-cancer-patients-cognitive-symptoms-after-information-about-chemotherapy-related-cognitive-symptoms-34624https://curecurrent.com/trials/decision-aid-on-breast-cancer-screening-34625https://curecurrent.com/trials/closed-incision-disposable-negative-pressure-wound-therapy-in-immediate-postmastectomy-breast-reconstruction-34626https://curecurrent.com/trials/sequentional-immuno-apheresis-plasma-volume-escalation-cohort-study-of-reduction-of-soluble-tumor-necrosis-factor-recept-34627https://curecurrent.com/trials/the-effect-of-resistive-exercise-on-forearm-blood-flow-and-tissue-oxygenation-among-breast-cancer-survivors-with-or-at-r-34628https://curecurrent.com/trials/magnetic-resonance-mr-spectroscopy-of-breast-cancer-tissue-34629https://curecurrent.com/trials/pd-1-inhibitor-concurrent-with-chemotherapy-as-neoadjuvant-therapy-for-tnbc-34630https://curecurrent.com/trials/involving-family-to-improve-communication-in-breast-cancer-care-34631https://curecurrent.com/trials/case-collection-study-to-determine-the-accuracy-call-back-and-cancer-detection-rates-of-qt-ultrasound-in-breast-imaging-34632https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-breast-cancer-34633https://curecurrent.com/trials/prognostic-significance-of-bioscore-in-nonmetastatic-breast-cancer-34634https://curecurrent.com/trials/case-collection-study-in-the-evaluation-of-doubling-time-rates-in-non-suspicious-breast-masses-using-qt-ultrasound-techn-34635https://curecurrent.com/trials/central-catheters-used-for-chemotherapy-in-women-with-breast-cancer-34636https://curecurrent.com/trials/neadjuvant-multi-agent-chemotherapy-or-letrozole-plus-ribociclib-in-luminal-b-her2-negative-breast-cancer-34637https://curecurrent.com/trials/prospective-cohort-study-depending-on-the-use-of-palliative-care-for-advanced-stage-of-cancer-patients-34638https://curecurrent.com/trials/breast-omega-3-free-fatty-acid-ph-0-34639https://curecurrent.com/trials/horizons-understanding-the-impact-of-cancer-diagnosis-and-treatment-on-everyday-life-34640https://curecurrent.com/trials/elective-internal-mammary-node-irradiation-in-women-with-node-positive-breast-cancer-34641https://curecurrent.com/trials/personalized-evidence-based-treatment-in-patients-with-invasive-breast-cancer-34642https://curecurrent.com/trials/randomized-phase-ii-study-of-preoperative-letrozole-femara-in-combination-with-avastin-in-hormone-receptor-positive-brea-34643https://curecurrent.com/trials/addressing-sexual-concerns-in-breast-cancer-patient-intervention-study-34644https://curecurrent.com/trials/to-assess-the-efficacy-of-the-lympha-in-the-prevention-of-lymphedema-following-axillary-dissection-for-breast-cancer-34645https://curecurrent.com/trials/exercise-cancer-and-cognition-the-ecco-study-34646https://curecurrent.com/trials/the-validity-and-reliability-of-fit-hansa-in-breast-cancer-patients-34647https://curecurrent.com/trials/biological-response-to-tamoxifen-tam-in-patients-with-breast-cancer-non-metastatic-rh-34648https://curecurrent.com/trials/new-techniques-to-evaluate-response-to-neoadjuvant-treatments-in-breast-cancer-aurora-34649https://curecurrent.com/trials/skeletal-events-of-hormonal-treatment-and-radiotherapy-in-patient-with-breast-cacer-34650https://curecurrent.com/trials/phase-ii-trial-of-the-cyclin-dependent-kinase-inhibitor-pd-0332991-in-patients-with-cancer-34651https://curecurrent.com/trials/study-to-learn-the-effect-of-drug-bay1817080-on-the-way-the-body-absorbs-distributes-and-excretes-another-drug-rosuvasta-34652https://curecurrent.com/trials/analgesic-efficacy-of-erector-spinae-plane-block-after-breast-cancer-surgery-34653https://curecurrent.com/trials/ten-fraction-adjuvant-hypofractionated-radiotherapy-in-node-positive-breast-cancer-34654https://curecurrent.com/trials/a-study-assessing-the-safety-and-efficacy-of-adding-ipatasertib-to-paclitaxel-treatment-in-participants-with-breast-canc-34655https://curecurrent.com/trials/an-extension-protocol-for-subjects-who-were-previously-enrolled-in-other-tivantinib-arq-197-protocols-34656https://curecurrent.com/trials/quantification-of-breast-radiotherapy-associated-late-toxicity-using-novel-ultrasound-techniques-34657https://curecurrent.com/trials/bruog-351-pre-operative-apbi-using-nibb-34658https://curecurrent.com/trials/a-study-of-sy-1365-in-adult-patients-with-advanced-solid-tumors-34659https://curecurrent.com/trials/effect-of-bevacizumab-in-metastatic-triple-negative-breast-cancer-34660https://curecurrent.com/trials/accelerated-partial-breast-irradiation-versus-standard-or-hypofractionated-whole-breast-irradiation-in-early-breast-canc-34661https://curecurrent.com/trials/diagnostic-and-prognostic-value-of-microrna-in-breast-cancer-patients-34662https://curecurrent.com/trials/the-use-of-cryotherapy-to-prevent-paclitaxel-induced-peripheral-neuropathy-and-nail-changes-in-women-with-breast-cancer-34663https://curecurrent.com/trials/lymphedema-prevention-after-lymph-node-emptying-34664https://curecurrent.com/trials/magseed-magnetic-marker-in-locating-axillary-lymph-nodes-in-patients-with-breast-cancer-undergoing-surgery-34665https://curecurrent.com/trials/provider-training-in-increasing-patient-tobacco-cessation-counseling-and-referrals-for-patients-with-cancer-undergoing-r-34666https://curecurrent.com/trials/painter-polymorphism-and-incidence-of-toxicity-in-eribulin-treatment-34667https://curecurrent.com/trials/clinical-study-of-recombinant-anti-her2-humanized-monoclonal-antibody-for-injection-34668https://curecurrent.com/trials/a-multicenter-ablate-and-resect-study-of-novilase-interstitial-laser-therapy-for-the-ablation-of-small-breast-cancers-34669https://curecurrent.com/trials/albumin-bound-paclitaxel-combination-with-capecitabine-versus-capecitabine-monotherapy-in-paclitaxel-docetaxel-resistant-34670https://curecurrent.com/trials/magnesium-and-ketamine-in-postoperative-analgesia-34671https://curecurrent.com/trials/pain-phenotyping-of-patients-with-bone-cancer-pain-34672https://curecurrent.com/trials/yoga-on-qol-physiological-distress-fatigue-on-patients-affected-by-breast-cancer-in-adjuvant-radiotherapy-34673https://curecurrent.com/trials/evaluation-of-sexual-quality-of-life-for-breast-cancer-34674https://curecurrent.com/trials/abraxane-in-patients-with-visceral-metastases-dominant-metastatic-breast-cancer-34675https://curecurrent.com/trials/a-phase-ii-study-of-everolimus-in-combination-with-exemestane-versus-everolimus-alone-versus-capecitabine-in-advance-bre-34676https://curecurrent.com/trials/effects-of-manual-therapy-on-chronic-pain-and-functionality-of-breast-cancer-survivors-34677https://curecurrent.com/trials/mri-guided-single-dose-preoperative-radiotherapy-in-low-risk-breast-cancer-34678https://curecurrent.com/trials/cost-effectiveness-of-abdominal-based-autogenous-tissue-vs-tissue-expander-implant-reconstruction-a-feasibility-study-34679https://curecurrent.com/trials/individualized-locoregional-treatment-of-initially-biopsy-proven-node-positive-breast-cancer-after-primary-systemic-ther-34680https://curecurrent.com/trials/ultrasonographic-axillary-localization-34681https://curecurrent.com/trials/wide-margin-vs-narrow-margin-in-postneoadjuvant-lumpectomy-34682https://curecurrent.com/trials/study-comparing-lapatinib-gw572016-and-letrozole-versus-letrozole-in-subjects-with-advanced-or-metastatic-breast-cancer-34683https://curecurrent.com/trials/anastrozole-or-fulvestrant-in-treating-postmenopausal-patients-with-breast-cancer-34684https://curecurrent.com/trials/study-of-antibody-drug-conjugate-in-patients-with-advanced-breast-cancer-expressing-her2-34685https://curecurrent.com/trials/ohio-patient-navigator-research-program-34686https://curecurrent.com/trials/pilot-trial-of-bmn-673-an-oral-parp-inhibitor-in-patients-with-advanced-solid-tumors-and-deleterious-brca-mutations-34687https://curecurrent.com/trials/abiraterone-acetate-in-molecular-apocrine-breast-cancer-34688https://curecurrent.com/trials/evaluation-of-the-treatment-response-in-breast-cancer-related-lymphedema-34689https://curecurrent.com/trials/effect-of-dexmedetomidine-on-the-duration-of-pain-control-in-esp-block-for-breast-surgery-34690https://curecurrent.com/trials/a-single-arm-study-of-brain-metastasis-in-patients-with-her2-positive-breast-cancer-34691https://curecurrent.com/trials/liposomal-doxorubicin-compared-with-observation-or-cyclophosphamide-and-methotrexate-in-treating-older-women-who-have-un-34692https://curecurrent.com/trials/interest-of-maintenance-chemotherapy-after-induction-treatment-for-inflammatory-breast-cancer-34693https://curecurrent.com/trials/seroma-reduction-post-mastectomy-seroma-study-34694https://curecurrent.com/trials/diagnostic-study-to-identify-sentinel-lymph-nodes-in-women-with-stage-i-or-stage-ii-breast-cancer-34695https://curecurrent.com/trials/studying-if-adding-night-compression-to-standard-care-will-have-improved-control-of-lymphedema-in-breast-cancer-subjects-34696https://curecurrent.com/trials/niraparib-combined-with-anlotinib-in-homologous-recombination-repair-hrr-gene-mutated-advanced-solid-tumors-34697https://curecurrent.com/trials/adaptations-to-breast-cancer-and-exercise-using-telehealth-abrace-telehealth-34698https://curecurrent.com/trials/cyberknife-for-early-stage-breast-cancer-34699https://curecurrent.com/trials/physical-activity-levels-and-functional-improvement-in-breast-cancer-survivors-34700https://curecurrent.com/trials/phase-ii-study-of-herzuma-plus-gedatolisib-in-patients-with-her-2-positive-metastatic-breast-cancer-34701https://curecurrent.com/trials/sentinel-lymph-node-biopsy-in-patients-with-breast-cancer-after-neoadjuvant-therapy-34702https://curecurrent.com/trials/image-guided-targeted-doxorubicin-delivery-with-hyperthermia-to-optimize-loco-regional-control-in-breast-cancer-34703https://curecurrent.com/trials/capecitabine-and-paclitaxel-albumin-stabilized-nanoparticle-formulation-in-treating-women-undergoing-surgery-for-stage-i-34704https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-trastuzumab-emtansine-in-combination-with-atezolizumab-or-atezolizumab-pl-34705https://curecurrent.com/trials/18f-fdg-uptake-heterogeneity-predicts-pyrotinib-response-34706https://curecurrent.com/trials/ultrasound-and-near-infrared-imaging-for-predicting-and-monitoring-neoadjuvant-treatment-34707https://curecurrent.com/trials/talazoparib-maintenance-therapy-in-triple-negative-breast-cancer-34708https://curecurrent.com/trials/tipifarnib-and-combination-chemotherapy-in-treating-patients-with-stage-ii-or-stage-iii-breast-cancer-34709https://curecurrent.com/trials/breath-test-to-predict-breast-cancer-and-outcome-of-mammography-34710https://curecurrent.com/trials/the-neoadjuvant-combined-hormone-therapy-in-premenopausal-women-with-locally-advanced-er-her2-breast-cancer-34711https://curecurrent.com/trials/addition-of-pd-l1-antibody-medi4736-to-a-taxane-anthracycline-chemotherapy-in-triple-negative-breast-cancer-34712https://curecurrent.com/trials/clinical-outcome-and-toxicity-data-in-patients-with-advanced-breast-cancer-treated-with-cdk-inhibitors-combined-with-end-34713https://curecurrent.com/trials/18f-flt-pet-in-breast-cancer-mk-0000-139-34714https://curecurrent.com/trials/influence-of-co-vid-19-pandemic-on-screening-mammography-single-institution-34715https://curecurrent.com/trials/a-study-of-hx008-for-the-treatment-of-patients-with-metastatic-triple-negative-breast-cancer-34716https://curecurrent.com/trials/aerobic-exercise-and-cognitive-functioning-in-women-with-breast-cancer-34717https://curecurrent.com/trials/prognostic-value-of-vitamin-d-levels-in-egyptian-females-with-breast-cancer-34718https://curecurrent.com/trials/phase-i-study-of-the-oral-pi3kinase-inhibitor-bkm120-or-byl719-and-the-oral-parp-inhibitor-olaparib-in-patients-with-rec-34719https://curecurrent.com/trials/a-novel-optical-spectral-imaging-system-for-imaging-breast-tumor-margins-34720https://curecurrent.com/trials/exercise-therapy-during-radiotherapy-34721https://curecurrent.com/trials/reatment-standards-and-outcomes-of-patients-with-er-pr-positive-her2-negative-metastatic-breast-cancer-34722https://curecurrent.com/trials/docetaxel-carboplatin-vs-epirubicin-cyclophosphamide-followed-by-docetaxel-as-adjuvant-treatment-in-triple-negative-brea-34723https://curecurrent.com/trials/health-economy-register-34724https://curecurrent.com/trials/phase-i-iia-trial-of-gemcitabine-plus-trastuzumab-and-pertuzumab-in-previously-treated-metastatic-her2-breast-cancer-34725https://curecurrent.com/trials/fractionated-stereotactic-radiotherapy-fsrt-in-treatment-of-brain-metastases-34726https://curecurrent.com/trials/study-of-the-impact-of-everolimus-treatment-on-lymphocytes-nk-natural-killer-development-and-functions-for-patients-with-34727https://curecurrent.com/trials/docetaxel-doxorubicin-and-cyclophosphamide-versus-vinorelbine-and-capecitabine-in-patients-not-sufficiently-sufficiently-34728https://curecurrent.com/trials/cicaderma-efficacy-vs-standard-care-of-sites-in-preventing-radiodermatitis-in-non-metastatic-breast-cancer-patients-34729https://curecurrent.com/trials/prevention-and-treatment-of-pyrrolitinib-associated-diarrhea-34730https://curecurrent.com/trials/delphinus-softvue-roc-reader-study-dmt-sv-rrs3-34731https://curecurrent.com/trials/registry-trial-to-evaluate-the-clinical-utilization-of-targeted-axillary-dissection-tad-34732https://curecurrent.com/trials/eribulin-in-combination-with-cyclophosphamide-in-patients-with-solid-tumor-malignancies-34733https://curecurrent.com/trials/inetetamab-plus-rapamycin-and-chemotherapy-for-her2-metastatic-breast-cancer-with-abnormal-activation-of-pam-pathway-34734https://curecurrent.com/trials/eribulin-in-mtnbc-patients-34735https://curecurrent.com/trials/protective-role-of-vitamin-d-in-breast-cancer-patients-treated-with-doxorubicin-34736https://curecurrent.com/trials/study-of-nab-paclitaxel-in-high-risk-early-breast-cancer-34737https://curecurrent.com/trials/immature-granulocyte-count-and-delta-neutrophil-index-factors-for-axillary-metastasis-of-breast-cancer-34738https://curecurrent.com/trials/web-based-communication-education-for-breast-cancer-survivorship-care-34739https://curecurrent.com/trials/acupressure-for-cancer-related-fatigue-34740https://curecurrent.com/trials/denosumab-as-an-add-on-neoadjuvant-treatment-geparx-34741https://curecurrent.com/trials/cwi-and-discharge-after-breast-cancer-surgery-34742https://curecurrent.com/trials/the-effects-of-cosmetic-care-on-body-image-in-young-chinese-breast-cancer-patients-receiving-chemotherapy-34743https://curecurrent.com/trials/study-of-adct-502-in-patients-with-advanced-solid-tumors-withhuman-epidermal-growth-factor-receptor-2-her2-expression-34744https://curecurrent.com/trials/immune-response-for-patients-with-metastatic-breast-cancer-treated-by-everolimus-34745https://curecurrent.com/trials/carboplatin-and-gemcitabine-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-34746https://curecurrent.com/trials/a-open-study-of-metronomic-oral-vinorelbine-in-combination-with-aromatase-inhibitors-for-the-treatment-of-postmenopausal-34747https://curecurrent.com/trials/phase-i-study-of-pyrotinib-in-patients-with-her2-positive-solid-tumors-34748https://curecurrent.com/trials/moving-on-an-rct-to-test-physical-therapy-education-34749https://curecurrent.com/trials/cluster-randomized-trial-comparing-interventions-to-enhance-genetic-counseling-among-breast-cancer-patients-34750https://curecurrent.com/trials/evaluation-of-icotinib-in-metastatic-triple-negative-breast-cancer-after-second-line-therapy-34751https://curecurrent.com/trials/evaluation-of-epalrestat-in-metastatic-triple-negative-breast-cancer-34752https://curecurrent.com/trials/sv-br-1-gm-in-metastatic-or-locally-recurrent-breast-cancer-34753https://curecurrent.com/trials/relationship-between-gut-microbiome-and-adjuvant-chemotherapy-in-patients-with-early-breast-cancer-34754https://curecurrent.com/trials/triptorelin-for-preserving-ovarian-function-in-premenopausal-women-receiving-chemotherapy-for-early-stage-breast-cancer-34755https://curecurrent.com/trials/impact-of-osteopathy-on-pain-after-breast-cancer-surgery-34756https://curecurrent.com/trials/s1222-trial-everolimus-anastrozole-and-fulvestrant-in-post-menopausal-stage-iv-breast-cancer-34757https://curecurrent.com/trials/intraoperative-imaging-of-breast-cancer-with-indocyanine-green-34758https://curecurrent.com/trials/resistance-versus-aerobic-exercises-on-breast-cancer-patients-34759https://curecurrent.com/trials/bicalutamide-in-treatment-of-androgen-receptor-ar-positive-metastatic-triple-negative-breast-cancer-34760https://curecurrent.com/trials/a-dose-exploration-study-with-birabresib-mk-8628-in-participants-with-selected-advanced-solid-tumors-mk-8628-006-34761https://curecurrent.com/trials/multicenter-phase-ii-study-of-apatinib-in-patients-with-advanced-breast-cancer-cabc006-34762https://curecurrent.com/trials/effectiveness-of-character-strengths-based-intervention-among-breast-cancer-patients-34763https://curecurrent.com/trials/breast-cancer-genes-brca-expressions-in-metastatic-gastric-cancer-34764https://curecurrent.com/trials/pilot-study-of-durvalumab-and-vigil-in-advanced-women-s-cancers-34765https://curecurrent.com/trials/double-blind-study-to-assess-effectiveness-of-pectoral-nerves-block-after-breast-surgery-on-piritramide-consumption-34766https://curecurrent.com/trials/supplementation-with-dietary-anthocyanins-and-side-effects-of-radiotherapy-for-breast-cancer-34767https://curecurrent.com/trials/safety-and-tolerability-of-a-modified-vaccinia-ankara-mva-based-vaccine-modified-to-express-brachyury-and-t-cell-costimu-34768https://curecurrent.com/trials/a-randomized-controlled-trial-of-routine-shave-margins-versus-standard-partial-mastectomy-in-breast-cancer-patients-34769https://curecurrent.com/trials/promoting-activity-in-cancer-survivors-34770https://curecurrent.com/trials/a-dose-finding-study-of-birabresib-mk-8628-a-small-molecule-inhibitor-of-the-bromodomain-and-extra-terminal-bet-proteins-34771https://curecurrent.com/trials/intermittent-high-dose-lapatinib-in-tandem-with-capecitabine-for-her2-overexpressed-amplified-metastatic-breast-cancer-w-34772https://curecurrent.com/trials/upper-limb-function-after-breast-cancer-surgery-the-role-of-post-operative-physical-therapy-intervention-34773https://curecurrent.com/trials/recombinant-human-chorionic-gonadotropin-in-preventing-breast-cancer-in-premenopausal-women-with-brca1-mutations-34774https://curecurrent.com/trials/intensified-iaa-with-pbpc-support-in-breast-tumors-with-evidence-of-a-hrd-34775https://curecurrent.com/trials/aberrant-expression-of-micro-rna-for-diagnosis-of-breast-cancer-34776https://curecurrent.com/trials/doxorubicin-hcl-liposome-injection-doxil-in-combination-with-abraxane-in-patients-with-metastatic-breast-cancer-34777https://curecurrent.com/trials/adherence-improving-self-management-strategy-aims-in-breast-cancer-patients-using-adjuvant-endocrine-treatment-aet-34778https://curecurrent.com/trials/pre-operative-hormonal-treatment-for-hormone-receptor-positive-breast-cancer-34779https://curecurrent.com/trials/a-combination-study-of-kadcyla-trastuzumab-emtansine-and-capecitabine-in-participants-with-human-epidermal-growth-factor-34780https://curecurrent.com/trials/the-meditate-bc-study-mindfulness-enhanced-decision-intervention-to-aid-treatment-election-breast-cancer-34781https://curecurrent.com/trials/dietary-advanced-glycation-end-products-inflammation-and-oxidative-stress-in-breast-cancer-patients-34782https://curecurrent.com/trials/a-study-to-assess-the-rel-bioavailability-food-effect-and-absolute-bioavailability-on-the-pharmacokinetics-of-azd9833-34783https://curecurrent.com/trials/a-study-evaluating-safety-and-efficacy-of-the-addition-of-abt-888-plus-carboplatin-versus-the-addition-of-carboplatin-to-34784https://curecurrent.com/trials/impact-of-the-covid-19-pandemic-in-gynecological-oncology-34785https://curecurrent.com/trials/lorcaserin-in-treating-chemotherapy-induced-peripheral-neuropathy-in-patients-with-stage-i-iv-gastrointestinal-or-breast-34786https://curecurrent.com/trials/nbrst-prospective-neo-adjuvant-registry-trial-34787https://curecurrent.com/trials/prospective-trial-of-two-prone-breast-radiotherapy-techniques-with-randomization-to-concurrent-versus-weekly-boost-34788https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-to-improve-fatigue-and-cognitive-function-34789https://curecurrent.com/trials/treatment-of-breast-cancer-related-lymphedema-with-a-negative-pressure-device-34790https://curecurrent.com/trials/plinabulin-vs-pegfilgrastim-in-prevention-of-tac-induced-neutropenia-34791https://curecurrent.com/trials/a-study-of-poziotinib-in-combination-with-t-dm1-in-her2-positive-breast-cancer-34792https://curecurrent.com/trials/magnetic-seed-localisation-of-breast-cancers-34793https://curecurrent.com/trials/image-guided-radiotherapy-igrt-for-prone-partial-breast-irradiation-34794https://curecurrent.com/trials/investigating-public-enthusiasm-for-mammography-screening-in-denmark-34795https://curecurrent.com/trials/the-master-study-mammary-cancer-statin-er-positive-study-34796https://curecurrent.com/trials/association-of-tumour-grade-and-sex-steroid-receptor-as-a-prognostic-index-in-breast-cancer-34797https://curecurrent.com/trials/localization-of-intercostal-perforating-vessels-reduces-wound-complications-from-nipple-sparing-mastectomy-34798https://curecurrent.com/trials/s0226-anastrozole-with-or-without-fulvestrant-as-first-line-therapy-in-postmenopausal-women-with-metastatic-breast-cance-34799https://curecurrent.com/trials/whole-body-vibration-training-and-breast-cancer-risk-factors-34800https://curecurrent.com/trials/satisfaction-assessment-of-patients-with-local-breast-cancer-when-using-cosmetics-during-chemotherapy-and-post-treatment-34801https://curecurrent.com/trials/distress-reduction-by-activity-tracking-and-activity-enhancement-by-mobile-support-group-in-oncology-34802https://curecurrent.com/trials/concurrent-adjuvant-carboplatin-and-accelerated-radiotherapy-for-triple-negative-breast-cancer-34803https://curecurrent.com/trials/the-breast-cancer-physical-activity-level-bc-pal-pilot-study-34804https://curecurrent.com/trials/liposomal-bupivacaine-in-implant-based-breast-reconstruction-34805https://curecurrent.com/trials/efficacy-of-statin-addition-to-neoadjuvant-chemotherapy-protocols-for-breast-cancer-34806https://curecurrent.com/trials/esr1-mutations-in-asian-er-metastatic-breast-cancer-on-hormonal-therapy-based-treatments-34807https://curecurrent.com/trials/pre-surgical-intervention-for-targeted-therapies-for-breast-cancer-34808https://curecurrent.com/trials/a-confirmation-study-of-eribulin-in-combination-with-capecitabine-34809https://curecurrent.com/trials/bioimpedance-spectroscopy-versus-tape-measure-in-prevention-of-lymphedema-prevent-34810https://curecurrent.com/trials/a-phase-i-ii-trial-of-her-2-neu-pulsed-dc1-vaccine-combined-with-trastuzumab-for-patients-with-dcis-34811https://curecurrent.com/trials/know-your-risk-assessment-at-screening-for-breast-cancer-pilot-study-34812https://curecurrent.com/trials/merestinib-on-bone-metastases-in-subjects-with-breast-cancer-34813https://curecurrent.com/trials/an-initial-safety-study-of-gedatolisib-plus-ptk7-adc-for-metastatic-triple-negative-breast-cancer-34814https://curecurrent.com/trials/acy-1215-nab-paclitaxel-in-metastatic-breast-cancer-34815https://curecurrent.com/trials/the-benefit-of-surgery-in-stage-iv-of-breast-cancer-34816https://curecurrent.com/trials/what-matters-most-choosing-the-right-breast-cancer-surgery-for-you-34817https://curecurrent.com/trials/impact-of-exercise-on-mitigating-the-cardio-toxic-effects-of-adriamycin-among-women-newly-diagnosed-with-breast-cancer-34818https://curecurrent.com/trials/a-study-of-lxi-15029-in-patients-with-advanced-malignant-solid-tumors-34819https://curecurrent.com/trials/effects-of-yoga-on-phase-angle-and-quality-of-life-in-patients-with-breast-cancer-34820https://curecurrent.com/trials/genetic-risk-estimation-of-breast-cancer-prior-to-preventive-medication-uptake-34821https://curecurrent.com/trials/functional-mri-in-predicting-response-to-chemotherapy-34822https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-alobresib-formerly-gs-5829-in-adults-with-34823https://curecurrent.com/trials/the-ultrasound-study-of-tamoxifen-34824https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-immunogenicity-of-leucostim-versus-neupogen-in-breast-cancer-patients-34825https://curecurrent.com/trials/prognostic-value-of-biomarkers-in-hr-her2-advanced-breast-cancer-34826https://curecurrent.com/trials/efficacy-and-safety-of-eribulin-in-the-treatment-of-advanced-breast-cancer-34827https://curecurrent.com/trials/the-establishment-of-a-survival-prediction-model-for-er-positive-her-2-negative-advanced-breast-cancer-34828https://curecurrent.com/trials/radiotherapy-for-thoracic-and-breast-cancer-and-the-related-cardiotoxicity-following-treatment-raccoon-34829https://curecurrent.com/trials/inetetamab-combined-with-pyrotinib-and-chemotherapy-in-the-treatment-of-her2-positive-metastatic-breast-cancer-34830https://curecurrent.com/trials/moving-on-study-pilot-test-34831https://curecurrent.com/trials/pyrotinib-in-combination-with-fulvestrant-in-patients-with-her2-positive-hr-positive-metastatic-breast-cancer-34832https://curecurrent.com/trials/isolation-of-volatile-organic-compounds-vocs-related-to-the-olfactory-signature-of-breast-cancer-34833https://curecurrent.com/trials/neoadjuvant-study-of-camrelizumab-plus-chemotherapy-in-triple-negative-breast-cancer-tnbc-34834https://curecurrent.com/trials/dose-finding-study-of-rad001-everolimus-afinitor-in-combination-with-bez235-in-patients-with-advanced-solid-tumors-34835https://curecurrent.com/trials/pharmacokinetic-drug-drug-interaction-study-of-dovitinib-tki258-in-patients-with-advanced-solid-tumors-34836https://curecurrent.com/trials/safety-of-everolimus-in-combination-therapy-in-patients-with-her2-overexpressing-metastatic-breast-cancer-34837https://curecurrent.com/trials/study-of-zoledronic-acid-administered-monthly-versus-every-3-months-in-multiple-myeloma-and-breast-cancer-patients-who-w-34838https://curecurrent.com/trials/bioequivalence-of-2-formulations-of-tki258-in-patients-with-advanced-solid-tumors-34839https://curecurrent.com/trials/pharmacokinetic-drug-drug-interaction-study-of-dovitinib-tki258-in-patients-with-advanced-solid-tumors-34840https://curecurrent.com/trials/everolimus-letrozole-and-trastuzumab-in-hr-and-her2-neu-positive-patients-34841https://curecurrent.com/trials/phase-ib-dose-escalation-study-of-oral-lde225-in-combination-with-bkm120-in-patients-with-advanced-solid-tumors-34842https://curecurrent.com/trials/pca062-in-pcad-positive-tumors-34843https://curecurrent.com/trials/safety-and-efficacy-of-tki258-in-fgfr1-amplified-and-non-amplified-metastatic-her2-negative-breast-cancer-34844https://curecurrent.com/trials/phase-i-study-ljm716-combined-with-trastuzumab-in-patients-with-her2-overexpressing-metastatic-breast-or-gastric-cancer-34845https://curecurrent.com/trials/dose-escalation-study-of-lee011-in-combination-with-buparlisib-and-letrozole-in-hr-her2-negative-post-menopausal-women-w-34846https://curecurrent.com/trials/study-of-inc280-in-patients-with-c-met-dependent-advanced-solid-tumors-34847https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-breast-cancer-non-small-cell-lung-cancer-or-melanoma-that-has-spre-34848https://curecurrent.com/trials/a-trial-l-of-panobinostat-given-in-combination-with-trastuzumab-and-paclitaxel-in-adult-female-patients-with-her2-positi-34849https://curecurrent.com/trials/a-phase-i-study-of-ljm716-in-squamous-cell-carcinoma-of-head-and-neck-or-her2-breast-cancer-or-gastric-cancer-34850https://curecurrent.com/trials/physical-activity-in-reducing-metabolic-dysregulation-metd-in-obese-latina-breast-cancer-survivors-34851https://curecurrent.com/trials/study-of-lee011-with-fulvestrant-and-byl719-or-bkm120-in-advanced-breast-cancer-34852https://curecurrent.com/trials/a-study-of-pf-06647020-for-adult-patients-with-advanced-solid-tumors-34853https://curecurrent.com/trials/neoadjuvant-chemotherapy-response-in-metaplastic-carcinoma-of-triple-negative-breast-cancer-34854https://curecurrent.com/trials/psychological-factors-and-oncological-outcomes-of-triple-negative-breast-cancer-34855https://curecurrent.com/trials/phase-i-ii-study-to-determine-the-maximum-tolerated-dose-mtd-of-auy922-in-advanced-solid-malignancies-and-efficacy-in-he-34856https://curecurrent.com/trials/phase-i-study-of-lfa102-in-patients-with-prolactin-receptor-positive-castration-resistant-prostate-cancer-or-prolactin-r-34857https://curecurrent.com/trials/a-phase-i-ii-study-of-bgt226-in-adult-patients-with-advanced-solid-malignancies-including-patients-with-advanced-breast-34858https://curecurrent.com/trials/monocenter-open-label-clinical-investigation-on-the-treatment-of-radiation-induced-dermatitis-with-xonrid-34859https://curecurrent.com/trials/vitamin-d-supplementation-in-women-with-dcis-and-or-lcis-34860https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-monotherapy-for-metastatic-triple-negative-breast-cancer-mk-3475-086-keynote-086-34861https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-and-chemotherapy-in-her2-positive-mbc-34862https://curecurrent.com/trials/cancer-obesity-overweight-and-insomnia-study-34863https://curecurrent.com/trials/nomogram-to-predict-breast-cancer-related-lymphedema-34864https://curecurrent.com/trials/effects-of-bromelain-and-boswellia-serrata-casperome-with-centella-asiatica-and-vitamins-on-edema-paresthesia-and-postop-34865https://curecurrent.com/trials/effect-of-endocrine-therapy-duration-on-clinical-outcome-of-patients-with-hr-intraductal-carcinoma-of-the-breast-34866https://curecurrent.com/trials/nutritional-preferences-and-product-accessibility-in-oral-nutritional-supplements-in-participants-with-breast-colorectal-34867https://curecurrent.com/trials/helena-study-an-observational-study-of-perjeta-pertuzumab-in-first-line-treatment-in-patients-with-her2-positive-advance-34868https://curecurrent.com/trials/neoadjuvant-study-of-navelbine-in-patients-with-her2-positive-breast-cancer-34869https://curecurrent.com/trials/preventing-taxane-related-peripheral-neuropathy-pain-and-nail-toxicity-a-prospective-self-controlled-trial-comparing-hil-34870https://curecurrent.com/trials/99mtc-rhannexin-v-128-imaging-and-cardiotoxicity-in-patients-with-early-breast-cancer-34871https://curecurrent.com/trials/multimodal-imaging-evaluation-system-of-axillary-lymph-node-staging-and-treatment-strategy-for-breast-cancer-neoadjuvant-34872https://curecurrent.com/trials/identification-and-preservation-of-arm-lymphatics-34873https://curecurrent.com/trials/a-trial-of-oral-bez235-and-bkm120-in-combination-with-paclitaxel-with-or-without-trastuzumab-34874https://curecurrent.com/trials/efficacy-and-safety-of-gtx-024-in-patients-with-estrogen-receptor-er-androgen-receptor-ar-breast-cancer-34875https://curecurrent.com/trials/neoadjuvant-chemo-endocrine-therapy-and-immunotherapy-for-pre-menopausal-luminal-b-breast-cancer-patients-34876https://curecurrent.com/trials/a-study-to-investigate-safety-pharmacokinetics-pk-and-pharmacodynamics-pd-of-bkm120-plus-gsk1120212-in-selected-advanced-34877https://curecurrent.com/trials/nab-paclitaxel-in-combination-with-pyrotinib-in-postoperative-adjuvant-therapy-for-her2-positive-breast-cancer-34878https://curecurrent.com/trials/a-phase-i-study-of-bkm120-in-adult-chinese-patients-with-advanced-solid-tumors-34879https://curecurrent.com/trials/a-phase-i-ii-study-of-bez235-in-patients-with-advanced-solid-malignancies-enriched-by-patients-with-advanced-breast-canc-34880https://curecurrent.com/trials/phase-1b-trial-of-bgj398-byl719-in-solid-tumors-34881https://curecurrent.com/trials/a-phase-ib-ii-study-of-bez235-and-trastuzumab-in-patients-with-her2-positive-breast-cancer-who-failed-prior-to-trastuzum-34882https://curecurrent.com/trials/improving-emotion-regulation-at-the-end-of-breast-cancer-treatment-34883https://curecurrent.com/trials/phase-ib-ii-trial-of-bez235-with-paclitaxel-in-patients-with-her2-negative-locally-advanced-or-metastatic-breast-cancer-34884https://curecurrent.com/trials/sonazoid-contrast-enhanced-ultrasound-in-assessing-effectiveness-of-neoadjuvant-chemotherapy-in-breast-cancer-patients-34885https://curecurrent.com/trials/safety-of-bkm120-monotherapy-in-advanced-solid-tumor-patients-34886https://curecurrent.com/trials/combination-of-auy922-with-trastuzumab-in-her2-advanced-breast-cancer-patients-previously-treated-with-trastuzumab-34887https://curecurrent.com/trials/study-of-safety-and-efficacy-of-alpelisib-with-everolimus-or-alpelisib-with-everolimus-and-exemestane-in-advanced-breast-34888https://curecurrent.com/trials/effect-of-anesthesia-on-expression-of-programmed-death-1-and-programmed-death-1-ligand-in-breast-cancer-34889https://curecurrent.com/trials/a-study-to-evaluate-the-potential-benefit-of-the-addition-of-byl719-to-paclitaxel-in-the-treatment-of-breast-cancer-and-34890https://curecurrent.com/trials/neoadjuvant-treatment-of-early-triple-negative-breast-cancer-with-chidamide-and-chemotherapy-34891https://curecurrent.com/trials/feasibility-study-on-the-characterization-of-the-immune-profile-of-young-patients-after-treatment-for-breast-cancer-34892https://curecurrent.com/trials/case-collection-study-to-support-digital-mammography-image-software-change-34893https://curecurrent.com/trials/effects-of-a-paleolithic-lifestyle-intervention-in-breast-cancer-patients-undergoing-radiotherapy-34894https://curecurrent.com/trials/study-of-abcb1-slc22a16-drug-transporter-genes-and-doxorubicin-and-cyclophosphamide-toxicity-in-brest-cancer-patient-34895https://curecurrent.com/trials/pet-ct-imaging-using-fdg-labeled-human-erythrocytes-in-breast-cancer-patient-34896https://curecurrent.com/trials/tamoxifen-or-letrozole-in-treating-women-with-ductal-carcinoma-in-situ-34897https://curecurrent.com/trials/the-pioneer-initiative-precision-insights-on-n-of-1-ex-vivo-effectiveness-research-based-on-individual-tumor-ownership-p-34898https://curecurrent.com/trials/brief-behavioral-intervention-for-insomnia-during-chemotherapy-34899https://curecurrent.com/trials/use-of-gelronate-gel-vs-aloevera-in-preventing-minimizing-radiation-induced-dermatitis-in-breast-cancer-patients-34900https://curecurrent.com/trials/maintenance-aromatase-inhibitors-ais-everolimus-vs-ais-in-hormone-receptor-positive-metastatic-breast-cancer-patients-34901https://curecurrent.com/trials/4-weekly-versus-12-weekly-administration-of-bone-targeted-agents-in-patients-with-bone-metastases-34902https://curecurrent.com/trials/combination-immunotherapy-with-herceptin-and-the-her2-vaccine-neuvax-34903https://curecurrent.com/trials/apatinib-combined-with-oral-etoposide-in-metastatic-her2-negative-breast-cancer-34904https://curecurrent.com/trials/mirvetuximab-soravtansine-as-first-line-in-treating-patients-with-triple-negative-breast-cancer-34905https://curecurrent.com/trials/esm-versus-om-a-randomized-controlled-trial-34906https://curecurrent.com/trials/pharmacokinetics-of-tamoxifen-and-its-metabolites-in-breast-cancer-patients-the-influence-of-a-dose-increase-in-phenotyp-34907https://curecurrent.com/trials/feasibility-of-short-breast-mri-sbmri-for-screening-patients-at-high-risk-for-breast-cancer-34908https://curecurrent.com/trials/fulvestrant-or-capecitabine-combined-with-pyrotinib-in-hr-her2-metastatic-breast-cancer-34909https://curecurrent.com/trials/real-world-evidence-prospective-study-on-the-effect-of-nab-paclitaxel-treatment-on-the-clinical-outcomes-and-hrqol-in-pa-34910https://curecurrent.com/trials/abbreviated-breast-mri-for-second-breast-cancer-detection-in-women-with-brca-mutation-testing-34911https://curecurrent.com/trials/microvascular-breast-reconstruction-with-lymph-node-transfer-34912https://curecurrent.com/trials/ixazomib-mln9708-in-combination-with-carboplatin-in-pretreated-women-with-advanced-triple-negative-breast-cancer-34913https://curecurrent.com/trials/effect-of-intercessory-prayer-in-patients-with-breast-cancer-in-radiotherapy-treatment-clinical-trial-34914https://curecurrent.com/trials/kortuc-intra-tumoural-hydrogen-peroxide-as-a-radiation-sensitizer-in-patients-with-locally-advanced-recurrent-breast-can-34915https://curecurrent.com/trials/breast-imaging-studies-in-women-at-high-genetic-risk-of-breast-cancer-menstrual-cycle-study-34916https://curecurrent.com/trials/neoadjuvant-letrozole-and-palbociclib-in-patients-with-stage-ii-iiib-breast-cancer-hr-her2-34917https://curecurrent.com/trials/petra-pertuzumab-and-trastuzumab-biosimilars-real-life-association-for-the-first-line-treatment-of-her2-positive-metasta-34918https://curecurrent.com/trials/iacs-010759-in-advanced-cancers-34919https://curecurrent.com/trials/drain-less-abdominally-based-breast-reconstruction-using-lysine-derived-urethane-adhesive-34920https://curecurrent.com/trials/tumor-bed-dose-delivery-using-a-breast-specific-radiosurgery-device-the-gammapod-a-clinical-feasibility-study-34921https://curecurrent.com/trials/sentimag-intraoperative-comparison-in-breast-cancer-34922https://curecurrent.com/trials/breast-cancer-screening-with-diffusion-weighted-mri-in-women-at-high-risk-for-breast-cancer-34923https://curecurrent.com/trials/a-study-of-oral-palbociclib-pd-0332991-a-cdk4-6-inhibitor-as-single-agent-in-japanese-patients-with-advanced-solid-tumor-34924https://curecurrent.com/trials/study-of-concurrent-paclitaxel-and-radiation-correlation-of-tumor-profiles-with-pathologic-response-34925https://curecurrent.com/trials/assessment-of-nipple-sparing-mastectomy-as-a-treatment-option-for-breast-cancer-34926https://curecurrent.com/trials/reducing-metabolic-syndrome-among-breast-cancer-survivors-34927https://curecurrent.com/trials/increasing-breast-cervical-and-colorectal-cancer-screening-and-hpv-vaccination-among-underserved-texans-34928https://curecurrent.com/trials/understanding-and-addressing-patient-and-provider-preferences-around-discussions-of-cost-of-breast-cancer-care-34929https://curecurrent.com/trials/olaparib-and-durvalumab-in-treating-participants-with-metastatic-triple-negative-breast-cancer-34930https://curecurrent.com/trials/optimization-of-systemic-treatment-strategies-in-elderly-patients-with-advanced-solid-malignancies-34931https://curecurrent.com/trials/pyrotinib-trastuzumab-and-abraxane-in-her2-positive-mbc-with-brain-metastasis-34932https://curecurrent.com/trials/reconstruction-of-partial-mastectomy-defects-with-pectoralis-myo-glandular-local-flap-34933https://curecurrent.com/trials/18f-asis-pet-ct-imaging-of-tissue-factor-expression-in-patients-with-primary-and-metastastic-cancer-34934https://curecurrent.com/trials/diffusion-tensor-imaging-in-predicting-development-of-chemotherapy-induced-peripheral-neuropathy-in-patients-with-breast-34935https://curecurrent.com/trials/succinylated-gelatin-for-prevention-of-fluid-retention-in-patients-with-breast-cancer-receiving-docetaxel-chemotherapy-34936https://curecurrent.com/trials/efficacy-and-safety-of-gtx-024-in-patients-with-androgen-receptor-positive-triple-negative-breast-cancer-ar-tnbc-34937https://curecurrent.com/trials/improvement-of-patient-experience-and-healthcare-providers-productivity-using-virtual-reality-in-the-field-of-radiation-34938https://curecurrent.com/trials/vaccine-therapy-and-qs21-in-treating-patients-with-metastatic-breast-cancer-34939https://curecurrent.com/trials/cryotherapy-vs-cryocompression-for-preventing-chemotherapy-induced-peripheral-neuropathy-in-women-undergoing-chemotherap-34940https://curecurrent.com/trials/can-flaxseed-prevent-broken-hearts-in-women-with-breast-cancer-study-34941https://curecurrent.com/trials/continuation-of-follow-up-of-des-exposed-cohorts-34942https://curecurrent.com/trials/an-observational-study-of-herceptin-sc-safety-in-breast-cancer-34943https://curecurrent.com/trials/efficacy-of-paxman-scalp-cooling-to-prevent-chemo-induced-alopecia-in-black-patients-with-breast-or-gyn-cancers-34944https://curecurrent.com/trials/mri-and-early-decision-making-in-chemotherapy-for-breast-cancer-34945https://curecurrent.com/trials/a-study-of-r1507-in-combination-with-letrozole-in-postmenopausal-women-with-advanced-breast-cancer-34946https://curecurrent.com/trials/pharmacokinetics-of-spi-2012-eflapegrastim-in-breast-cancer-patients-receiving-docetaxel-and-cyclophosphamide-tc-chemoth-34947https://curecurrent.com/trials/a-nutritional-intervention-to-decrease-breast-density-among-female-brca-breast-cancer-susceptibility-gene-carriers-34948https://curecurrent.com/trials/research-on-the-heterogeneity-of-taiwanese-breast-cancer-patients-by-next-generation-sequencing-ngs-tools-34949https://curecurrent.com/trials/five-sessions-intervention-to-facilitate-adaptation-to-breast-cancer-34950https://curecurrent.com/trials/improving-brain-function-after-breast-cancer-study-34951https://curecurrent.com/trials/transcriptomes-breast-ovarian-and-leukocyte-hereditary-genes-predisposing-to-breast-and-or-ovarian-cancer-34952https://curecurrent.com/trials/inertial-rehabilitation-in-women-after-mastectomy-34953https://curecurrent.com/trials/home-based-physical-activity-intervention-for-taxane-induced-cipn-34954https://curecurrent.com/trials/comparison-of-erector-spinae-plane-block-with-serratus-anterior-plane-block-for-breast-surgery-34955https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-clinical-activity-of-ro6870810-and-atezolizumab-pd-l1-antibody-in-pa-34956https://curecurrent.com/trials/virtual-reality-based-exercise-training-in-radiotherapy-period-after-breast-cancer-surgery-34957https://curecurrent.com/trials/stem-cell-injection-in-cancer-survivors-34958https://curecurrent.com/trials/cultivando-la-salud-a-breast-and-cervical-cancer-screening-promotion-program-for-low-income-puerto-rican-women-34959https://curecurrent.com/trials/long-term-improvement-of-quality-of-life-in-breast-cancer-patients-with-quality-of-life-diagnosis-and-therapy-34960https://curecurrent.com/trials/evaluation-of-the-smartbx-system-for-breast-biopsy-34961https://curecurrent.com/trials/the-connectedcancercare-pilot-study-ccc-34962https://curecurrent.com/trials/parsaclisib-in-newly-diagnosed-stage-i-iiic-triple-negative-or-her2-breast-cancer-34963https://curecurrent.com/trials/a-study-of-the-safety-of-subcutaneously-administered-trastuzumab-herceptin-in-participants-with-early-and-locally-advanc-34964https://curecurrent.com/trials/physical-activity-intervention-for-young-cancer-survivors-34965https://curecurrent.com/trials/effect-of-a-topical-ketamine-on-acute-and-chronic-pain-dose-finding-34966https://curecurrent.com/trials/the-role-of-c1q-tumor-necrosis-factor-related-protein-6-in-breast-cancer-34967https://curecurrent.com/trials/epothilone-ixabepilone-plus-capecitabine-versus-capecitabine-alone-in-patients-with-advanced-breast-cancer-34968https://curecurrent.com/trials/external-beam-partial-breast-irradiation-for-early-breast-cancer-40-gy-qd-over-2-weeks-34969https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-essential-oil-intervention-34970https://curecurrent.com/trials/novel-epothilone-plus-capecitabine-versus-capecitabine-alone-in-patients-with-advanced-breast-cancer-34971https://curecurrent.com/trials/a-dose-escalation-and-cohort-expansion-study-of-oral-eft508-in-subjects-with-advanced-solid-tumors-34972https://curecurrent.com/trials/abus-for-early-stage-breast-cancer-34973https://curecurrent.com/trials/a-safety-and-tolerability-study-of-incagn02385-in-select-advanced-malignancies-34974https://curecurrent.com/trials/the-recharge-low-carbohydrate-diet-trial-for-metastatic-cancer-34975https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-venetoclax-tablets-in-combination-with-capecitabine-tablets-in-adult-34976https://curecurrent.com/trials/cancer-prevention-and-treatment-demonstration-for-ethnic-and-racial-minorities-34977https://curecurrent.com/trials/the-efficacy-of-acupuncture-as-a-complementary-treatment-for-pain-and-anxiety-after-breast-cancer-surgery-34978https://curecurrent.com/trials/a-study-of-pertuzumab-in-combination-with-trastuzumab-plus-an-aromatase-inhibitor-in-participants-with-metastatic-human-34979https://curecurrent.com/trials/research-of-intensive-treatment-in-hormone-receptor-10-and-human-epidermal-growth-factor-receptor-2-negative-breast-canc-34980https://curecurrent.com/trials/a-trial-of-bkm120-a-pi3k-inhibitor-in-patients-with-triple-negative-metastatic-breast-cancer-34981https://curecurrent.com/trials/effectiveness-of-ultrasound-guided-erector-spinae-plane-block-against-ultrasound-guided-serratus-anterior-block-in-modif-34982https://curecurrent.com/trials/efficacy-and-safety-of-4-5mg-peg-rhg-csf-per-cycle-in-preventing-neutropenia-after-intensive-chemotherapy-for-breast-can-34983https://curecurrent.com/trials/impact-of-individualized-radiotherapy-plan-review-in-patients-receiving-adjuvant-radiotherapy-for-breast-cancer-34984https://curecurrent.com/trials/ultrasound-based-diagnostic-model-for-differentiating-malignant-breast-lesion-from-benign-lesion-34985https://curecurrent.com/trials/the-effect-of-ultrasound-guided-modified-pectoral-nerves-block-versus-ketamine-plus-magnesium-infusion-on-analgesic-prof-34986https://curecurrent.com/trials/brain-monitoring-for-high-risk-of-brain-metastases-in-metastatic-breast-cancer-34987https://curecurrent.com/trials/comparison-study-of-different-tumor-biopsy-method-for-sentinel-lymph-node-biopsy-in-breast-cancer-34988https://curecurrent.com/trials/tivozanib-in-combination-with-paclitaxel-in-patients-with-locally-recurrent-or-metastatic-triple-negative-breast-cancer-34989https://curecurrent.com/trials/developing-a-web-based-shared-decision-making-tool-for-fertility-preservation-34990https://curecurrent.com/trials/the-impact-of-the-oncotype-dx-breast-cancer-assay-on-treatment-decisions-in-a-canadian-population-34991https://curecurrent.com/trials/68ga-neobomb1-imaging-in-patients-with-malignancies-known-to-overexpress-gastrin-releasing-peptide-receptor-grpr-34992https://curecurrent.com/trials/pilot-study-of-skin-quality-improvement-after-adipose-drived-stem-cell-transfer-in-irradiated-breasts-34993https://curecurrent.com/trials/a-trial-of-shr-1210-an-anti-pd-1-antibody-in-combination-with-apatinib-in-patients-with-advanced-tnbc-34994https://curecurrent.com/trials/tucatinib-abemaciclib-herceptin-for-her2-mbc-34995https://curecurrent.com/trials/effect-of-quilting-sutures-on-post-operative-drainage-after-mastectomy-and-or-axillary-lymph-node-dissection-34996https://curecurrent.com/trials/phase-1b-study-of-pegylated-liposomal-doxorubicin-and-pembrolizumab-in-endocrine-resistant-breast-cancer-34997https://curecurrent.com/trials/effects-of-naturalistic-decision-making-model-based-oncofertility-care-education-34998https://curecurrent.com/trials/same-day-discharge-after-nipple-sparing-mastectomy-or-skin-sparing-mastectomy-with-breast-reconstruction-34999https://curecurrent.com/trials/trial-of-a-behavior-change-intervention-to-increase-aerobic-and-resistance-exercise-and-quality-of-life-in-older-prostat-35000